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 At the interface of heart function and brain function is cerebrovascular function. The 
hundreds of miles of cerebrovasculature within our compact skulls exists to assure delivery of 
vital life substrates to brain tissue. A healthy cerebrovasculature is important to aging, as 
evidenced in age-related afflictions, including stroke and dementias. Cerebrovascular function is 
of tremendous interest to numerous fields, including, but not limited to, gerontology, physical 
therapy, rehabilitation medicine, psychology, neurology, and neurosurgery. Although we have 
made substantial advancements in understanding the aging brain, there are unanswered questions 
regarding cerebrovascular function which could ultimately impact our understanding of brain 
aging. 
 This body of work addresses gaps regarding the role of cerebrovascular function in the 
aging brain, and it has potential clinical implications regarding cerebrovascular dysfunction in 
stroke and dementias. The aim of this work was to elucidate the links between resting and 
exercise-induced cerebrovascular function and three markers of brain aging: executive function, 
brain structural integrity, and β-amyloid, a cellular hallmark of Alzheimer’s disease pathology. 
Our analyses of exercise-induced cerebrovascular functions revealed links between 
cerebrovascular responsiveness and these brain aging markers. Hence, the findings are a prelude 
to further investigation into cerebrovascular responsiveness and its links to brain aging.  
 Long-term development of markers of cerebrovascular responsiveness may provide 
researchers and clinicians with surrogate markers of brain pathological risk, i.e., a non-invasive 
marker of stroke or dementia risk. This could then serve as the basis for implementing brain-
sparing interventions, particularly exercise interventions in high-risk populations. Therefore, this 
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work lays the foundation for assessing whether longitudinal exercise-induced cerebrovascular 
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1.1. Overview  
 Cerebrovascular function is an important component for maintaining healthy brain aging. 
The cerebrovasculature’s primary function is to meet the disproportionately high metabolic 
demands of brain tissue through the flow-pressure relationship. This balance between blood 
pressure and blood flow allows for an adequate and steady supply of blood to neurons and glial 
cells (1). While prior work has focused primarily on neuronal networks that may promote 
healthy brain aging, relatively few studies have concentrated on cerebrovascular mechanisms 
that might underlie improved cognitive function (2). Further, our knowledge of how to preserve 
or enhance cerebrovascular function longitudinally across the aging spectrum is lacking. 
Modifiable cardiovascular risk factors such as maintaining normal blood pressure (3), avoiding 
diabetes (4) and being physical active (5, 6), may have significant roles to maximize 
cerebrovascular function. Cerebrovascular function measures are used as surrogate markers for 
brain health (2, 7). Cerebrovascular reserve capacity (CVRC), of the middle cerebral artery 
(MCA) has been used as a marker of cerebrovascular function. Cerebrovascular reserve capacity 
has been calculated as the change in mean MCA velocity (MCAv mean, in cm*sec-1) from a 
resting condition in response to some stimulus, such as carbon dioxide or exercise (2, 8-11). A 
second measure of cerebrovascular function is the cerebrovascular conductance index (CVCI), 
which describes the relationship of MCAv to mean arterial pressure (12), thus capturing the 
flow-pressure relationship in response to physiological stress (13-15). To measure the MCAv 
mean, Transcranial Doppler (TCD) ultrasound is used as a non-invasive alternative to scanner-
based neuroimaging. The main goal of this project is to better understand whether MCAv mean, 
CVCI, and CVRC is related to cognition and brain structural integrity, specifically white matter 
lesions (WML) burden, in people who were considered to be cognitively normal. Our work lays 
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the foundation for using MCAv mean, CVCI, and CVRC as measures of cerebrovascular health 
and as potential biomarkers of brain aging.  
 
1.2. Brain Blood Flow and the Aging Brain 
 There is strong evidence suggesting cerebrovascular health is an essential component of 
brain aging (7, 16-20). The brain’s cerebrovasculature is a vast network of blood vessels, with an 
estimated 400 miles of capillaries, designed to maintain brain hemodynamics, or brain blood 
flow (1, 21, 22). The cerebrovasculature burdens the responsibility of continual transportation of 
oxygen and energy, from aerobic metabolism, to brain tissue. This is because the brain demands 
a tremendous portion of the body’s energy, with an estimated 20% of cardiac output dedicated to 
brain function, yet sufficient brain energy storage is lacking (21). Without this continued supply 
of vital materials, brain function ceases within seconds, and the brain is at risk of cell death 
within minutes (23). Specifically, the normal hemodynamic rate is between 50-55 ml/100g/min 
of brain tissue, and at rates between 25-30 ml/100g/min altered consciousness and 
electroencephalogram brain wave abnormalities occur. When the hemodynamic rate drops below 
20 ml/100g/min, neurons convert to anaerobic metabolism, which leads to increases in lactate 
and H+ concentrations. At rates between 10-12 ml/100g/min, neurotransmission ceases, Na+/K+ 
pumps stop, and cytotoxic neuronal edema begins. Glutamate and Ca+-dependent neuronal death 
begin once rates reach 6-10 ml/100g/min (24).  
One of the age-associated risks is decreased brain hemodynamics, seen in both 
pathological and nonpathological aging. A review of the literature shows decreased 
hemodynamics as an important factor in a multitude of brain diseases including Parkinson’s 
disease, Huntington’s, dementia, and stroke (25-28). The average yearly global and regional 
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brain hemodynamic decreases vary depending on study. In healthy adults, one study established 
an average regional decrease of approximately 0.5% a year. This was seen in a study of 34 
healthy volunteers, ages 22-82, who underwent positron emission tomography (PET) (29) . 
However, more recent studies suggest that the decrease is between 0.78% and 1.2% per year (30, 
31). This is in stark contrast to the estimated 6.2%, 8.1%, and 8.6% yearly decreases in computer 
tomography (CT)-measured global brain blood flow, parietal cortex regional brain blood flow, 
and frontal cortex regional brain blood flow , respectively, seen in older adult with cognitive 
decline and dementia (32). One possible reason for the discrepancies may be due to differing 
methodology, as each study used a different imaging modality (PET vs. CT vs. magnetic 
resonance imaging (MRI) vs. magnetic resonance angiography). A second possible reason may 
be due to non-standardized quantification of blood flow, as some studies use ml/100g/min as the 
flow unit while other studies use mL/min.  Regardless of the imaging tool or unit of measure 
used, the decades of evidence suggests that brain hemodynamics declines across the lifespan. 
 
1.3. Cerebrovascular Regulation  
 Cerebrovascular regulation is an intricate process that is largely affected by the partial 
pressure of arterial carbon dioxide (PaCO2), mean arterial pressure (MAP), neurovascular 
coupling, and autonomic nervous system functioning (33). Therefore, this process is integrative, 
balancing neural, cardiovascular, and pulmonary functions. Regional brain blood flow regulation 
is associated with local neural metabolic demand. Hence, hemodynamics and neurovascular 
coupling have reciprocating effects on each other. Neurovascular coupling describes the 
functional relationship between neurons, glia, cerebrovasculature (particularly the pial vessels), 
and local metabolic demand. For instance, the response to hypoxia relies on excitation of the 
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astrocytes, which stimulate the production of vasodilators in order to affect increased 
hemodynamics (34). 
The cerebrovasculature is particularly sensitive to changes in carbon dioxide. For 
instance, there is up to a 6% increase in hemodynamics BBF velocity for every 1 mg Hg increase 
above eupneic PaCO2 and up to a 3% decrease in hemodynamics for every 1 mm Hg decrease 
below eupneic PaCO2 (33). Hemodynamics increases with increasing levels of hypoxia, but the 
levels of PaCO2 also controls the cerebrovasculature’s response to hypoxia, such that hypercapnia 
increases hemodynamics, but hypocapnia decreases hemodynamics (35). Although the cerebral 
arteries are sensitive to changes in blood gas concentrations and perfusion pressure, the pial 
arterioles are responsible for modulating cerebrovascular resistance, and therefore, regional 
hemodynamics. For instance, in hypocapnia, the smooth muscles contract, leading to vessel 
constriction and increased cerebrovascular resistance, which ultimately leads to a decrease in 
hemodynamics. However, hypercapnia results in relaxation of the smooth muscles and pial artery 
dilatation (up to 40%) to effect a net increase in hemodynamics (36).  
 The relationship between MAP and hemodynamics (see section 1.5.2. Flow-pressure 
Relationships and the Vasomotor Response) has provided the basis for studying cerebrovascular 
regulation, the homeostatic process in which hemodynamics remain stable over a wide range of 
arterial pressures. Lassen’s classic review paper and autoregulatory graph (Figure 1A, adapted 
from Willie’s  review paper (33)) plotting brain blood flow vs blood pressure (plotted using data 
from seven studies) shows that hemodynamics  rises as arterial pressures rises, but a plateau is 
reached and maintained at pressures between 60 mm Hg and 150 mm Hg. “Lassen’s curve” has 
become a cornerstone concept to those studying in the fields of anesthesia, neurosonology, and 
neurosurgery (37-39).  However, separate work by Tan and Willie and colleagues have 
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challenged this convention by suggesting the stable autoregulatory plateau is much thinner 
(Figure 1B), and therefore smaller than Lassen’s hypothetical 90 mm Hg gap (33, 40). Willie 
points out that this may be due to different methodologies interacting with established 
physiology, mainly the baroreflex. Specifically, the baroreflex limits the range of blood pressures 
which can be studied (41), which then constrains experimental manipulation of hemodynamics  
via use of vasoactive drugs, gases (see next section), postural changes, or exercise. Hence, the 
cerebrovascular response is not fully understood, but there are current efforts such as this work 
and others (see Appendix) (42), which strive to add to our understanding of the dynamic 





Figure 1. The Relationships between Perfusion Pressure and Hemodynamics. Classic and 
contemporary autoregulatory models adapted from Willie’s review article, page 487, figure 3 
(33). A) Lassen’s classic autoregulatory curve, showing brain blood flow remains stable over a 
wide range of pressures, and a plateau is reached and maintained between 50-60 mm Hg and 150 
mm Hg. B) Recent work challenges the classic autoregulatory curve by suggesting the stable 
autoregulatory plateau is a much smaller range (33, 40). Recreated with permission. © 2014 The 
Authors. The Journal of Physiology © 2014 The Physiological Society. 
 
1.4. Neuroimaging markers of cerebrovascular aging 
1.4.1. White matter lesion burden 
 White matter lesions (WML) are a phenomenon associated with aging (43). These areas 
of infarct-like lesions appear as hyperintensities on T2-weighted FLAIR neuroimages, and the 
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volume of WMLs increase as individuals surpass 60 years of age. One report suggests that over 
90% of adults over age 65 have WMLs (44). Clinically, WMLs are associated with Alzheimer’s 
disease (AD), dementia, impaired motor function and reduced cognitive capacity (44, 45). 
Impaired cerebrovascular infrastructure is implicated in WMLs, as histopathology studies 
provide evidence of brain blood barrier leakage associated with WMLs in AD and cognitively 
normal aging (46, 47). White matter lesions are associated with an increased risk for 
cerebrovascular disease, stroke, and dementia (48). Furthermore, because WMLs are associated 
with classic cardiovascular risk factors, such as hypertension and elevated plasma cholesterol 
(49), WML burden is used to identify cerebrovascular pathology in the elderly (50).  
 There is a body of work suggesting that WMLs are important in discerning pathological 
brain aging. For instance, having moderate to severe WML burden may be sufficient to 
characterize an individual as having vascular cognitive impairment (51).  This is substantiated by 
reports of individuals with moderate to severe WML burden being at high risk for developing 
more lesions and cognitive decline (51, 52). One study suggests WMLs can differentiate between 
mild cognitive impairment (MCI) subtypes. A report on the Washington Heights Inwood 
Columbia Aging Program (WHICAP) published in 2009, assessed the relationship between 
WML and MCI subtypes in 679 adults over the age of 65 (53). The 97 amnestic MCI and 74 
non-amnestic MCI adults were compared to 508 cognitively normal older adults on appearance 
of infarcts and WML volume, as a percentage of total intracranial volume. A T-test on the log-
transformed WML values revealed that the amnestic MCI group had a significantly higher total 
WML intracranial percentage than the normal cognition group. Second, regression analysis 
revealed that the amnestic MCI group had higher odds of having WMLs (OR = 1.9, 1.1-3.4 95% 
CI) compared to the normal cognition group. Third, in regards to cognitive performance, 
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regression analysis showed WMLs to be significantly and negatively related to language (r = -
0.16, p < 0 .05), and a negative trend emerged between WMLs and memory (r = -0.10, p =0.07). 
Fourth, adults with non-amnestic MCI were almost twice as likely to have infarcts as adults with 
amnestic MCI (53). Adults with MCI are considered to have significant impairment that is less 
than the impairment that is associated with Alzheimer’s. Therefore, this data suggests that adults 
who have preclinical AD have more WMLs than adults who do not have preclinical AD. 
Furthermore, adults whose main cognitive impairment was amnesia were about twice more 
likely to have WMLs than adults without impairment and 20% were more likely to have WMLs 
than adults categorized as non-amnestic. Finally, the data suggests that differentiation between 
amnestic and non-amnestic MCI can be determined by the infarct or WML appearance. 
Specifically, infarcts appear to be the distinguishing neuroimaging factor in labeling an 
individual as having non-amnestic MCI, while WMLs are more likely to identify adults with 
amnestic MCI. However, this conclusion should be viewed with caution as infarcts and WMLs 
are not easily differentiated when viewing MRI scans.  A separate study looked to parse out 
WMLs and infarcts, but the data suggests difficulty in separating the two. Authors reported that a 
third of adults who had the most WMLs also had infarcts, suggesting there was significant 
overlap in WMLs and infarcts (54).  Therefore, WMLs may not be the differentiating factor 
between amnestic subtypes, which is what the authors of the WHICAP study suggest. 
Nonetheless, the WHICAP study showed that WMLs can be a distinguishing marker between 
normal and pathological aging.  
 Although the WHICAP study suggests using WML burden as a marker for dementia 
progression, there are important criticisms against using WML burden as a specific marker for 
cerebrovascular function. The criticisms date back to over 30 years ago to the first study to 
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establish the link between WMLs and normal aging (43, 55). The first part of the study looked at 
240 patients over a 6 month period and looked at the severity of WMLs. These patients spanned 
a wide age of characteristics, including age (range was 5 to 82 years; median age = 46 years) and 
clinical presentation, as only patients with head trauma, craniotomy, and demyelinating disease 
were excluded. The WMLs were graded in increasing severity from 0-3. The percentage of 
patients with WMLs increased with age, with 51% of patients 41-60 years and 92% of patients 
over 65 having at least one WML. As age increased over 40 years, WML frequency and severity 
increased. Interestingly, WML frequency was the same in the 14 elderly patients with dementia 
and 68 patients without dementia. Multiple relationships between WMLs and vascular health 
were discovered. In patients over 50 years, a history of brain ischemia was related to increases in 
WML incidence, specifically an increase in multiple, bilateral confluent WMLs. Independent of 
age, hypertension was related to increased frequency of WMLs, which were mostly multiple, 
non-confluent lesions. Age was related to WML incidence and severity in the 33 elderly patients 
without a prior history of cerebrovascular disease, hypertensions diabetes, coronary artery 
disease, or dementia. However, when breaking down the elderly cohort into three groups (51-60 
years, 61-70 years, and older than 70 years), there were no significant relationships with WML 
frequency and severity. Regression analysis revealed that age, history of brain ischemia, and 
hypertension were significant predictors of WML presence and severity.  The second part of this 
study looked at seven post-mortem and one pre-mortem brain in patients who were 
asymptomatic for neurological disease (55). Subcortical lesions were mostly concentrated around 
the ventricles, and ventricular WMLs were the most prevalent hyperintensities, showing up in 6 
of the 8 brains. The lesions were associated with a variety of histological pathology features. The 
“mild” pathology included enlarged spaces surrounding the perivascular tissues and ectasia 
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(distention of the vascular tubular structures of the cerebral arteries and veins); “severe” 
pathology included myelin degradation and glial death.  However, the histopathology and MRI 
data were not related. The authors concluded that the MRI data could not differentiate between 
mild, vascular histopathology and severe, non-vascular histopathology (43).  
 This work was very important to our understanding of neuropathology and aging, but 
there are some important limitations. First, although there was no difference between WML 
frequencies in older adults with dementia compared to those without, it is important to note that 
this cohort included adults over 50 years of age. Hence they compared WML frequency in adults 
with dementia to adults without, even though more than half of these nondemented adults were 
below the age of 60. Dementia prevalence increases with age, and dementia prevalence for adults 
under age 65 is approximately 0.5%-1% (56). Therefore the analysis may have erroneously 
included adults who were not at high enough age risk for developing dementia. Furthermore, 
grade 1 and grade 3 lesions appear to increase with age, and grade 2 lesions seem to decrease 
with age.  Thus, the inclusion of the 51-60 age group may have confounded the analysis and 
prevented any significant relationships from being discovered. Therefore, the authors’ conclusion 
of WMLs not differing between demented and nondemented aging must be accepted with 
caution. Second, although WMLs were related to cerebrovascular disease, in scans of patients 
over 40, WMLs were also related to patients with headaches and brain tumors. This suggests that 
different, unrelated clinical complaints are associated with WMLs, which further suggests that 
different pathologies can manifest as WMLs. This idea was corroborated by their second part of 
their study because their data suggests vascular and non-vascular pathology were both related to 
WMLs, and neuroimaging could not differentiate between the mild lesions versus the severe 
lesions. Hence, using WMLs are likely one of several measures to index cerebrovascular 
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function.  Therefore, testing other measures  such as MCAv mean, CVCI, and CVRC may prove 
to be valuable cerebrovascular function measures since: (1) the WML hyperintense signal 
reflects both vascular (mild, perivascular-related changes) and non-vascular (myelin degradation 
and gliosis) brain tissue changes, and (2) the WML hyperintense signal relates to non-
cerebrovascular conditions such as brain tumors and headaches. 
 
1.4.2. Neuroimaging Assessment of Brain Blood Flow 
 Scanner-based functional neuroimaging with and without gas administration has been an 
important tool for investigating brain hemodynamics across aging. Hemodynamics can be 
measured via various imaging techniques, including single photon emission computed 
tomography (SPECT), PET, and arterial-spin labeling (ASL) MRI. Briefly, SPECT and PET 
have been used to study brain hemodynamics  since the 1980s (57).  In the mid-to- late 20th 
century, gas administration, such as O2-inhalation, in conjunction with emerging imaging 
modalities allowed investigators to study brain hemodynamics in humans. This eventually led to 
the discovery of age-related hemodynamic decreases (58, 59).   
There are limitations associated with using neuroimaging and gas administration for 
hemodynamic assessment.  There are two major limitations associated with PET: participants are 
exposed to radiation,  and PET has a temporal resolution on the scale of tens of seconds (60). A 
limitation of fMRI is that it captures an indirect measure of brain blood flow. Second, the 
administration of the fMRI exam involves subjecting a participant to a loud and often closed-in 
space. Finally, poor temporal resolution is a major disadvantage associated with fMRI (61). The 
limitations of gas administration include participant hesitation to inhale radioactive gas and/or 
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delivery of the radioisotope via puncturing of neck tissue. Although these methods are widely 
used and acceptable, there are alternative noninvasive, measures with good temporal resolution 
that is used for studying brain blood flow: transcranial Doppler ultrasound (62-64). From this 
point forward, our discussion of cerebrovascular function will focus on transcranial Doppler 
ultrasound outcomes, particularly MCAv-centered measures. 
 
1.5. Middle Cerebral Artery Velocity and the Cerebrovascular Conductance Index 
1.5.1. Transcranial Doppler Ultrasound 
Transcranial Doppler (TCD) ultrasound is used to determine brain blood flow velocity in 
the vertebral arteries comprising the Circle of Willis.  The artery most studied is the middle 
cerebral artery (MCA), which can be insonated at depths around 50 mm (64, 65). In research 
studies, the MCA is the standard vessel of measurement during a TCD exam (2, 12, 66), and it is 
important because it perfuses 60-70% of the cerebral lateral surface (67). The upper MCA 
branches perfuse the frontal lobe, and the lower branches perfuse the parietal and temporal lobes. 
These branches penetrate into the brain, forming the lateral striate and lenticulostriate branches, 
which perfuse the internal capsule, global pallidus, basal ganglia, and putamen (67-69). The 
primary outcome of the research TCD exam is the MCAv (64). 
The MCA velocity (MCAv)-centered outcomes obtained from TCD are considered valid 
surrogate measures of brain blood flow (2, 7). Multiple studies suggest the diameter of large 
cerebral vessels remain constant during changes in blood pressure and end-tidal CO2 (ETCO2) 
(62, 70-72). Additionally, there is evidence from MRI/PET/133Xe -TCD comparisons that 
changes in MCAv correlate to changes in global hemodynamics (72-76). For instance, a 133Xe 
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study by Bishop showed a significant, moderate relationship, r = 0.424, between MCAv peak 
and global hemodynamics. Exposure to CO2 has also been used to show changes in MCAv peak 
and MCAv mean in multiple reports (77-81). For example, Piepgras and colleagues showed that 
acetazolamide injection increased the absolute MCAv by approximately 25 cm/s (percent change 
of 39%) over baseline MCAv (80). This blood flow velocity change attributed to vasoactive 
stimuli is the cerebrovascular reserve capacity (CVRC) (80, 81).  
 
1.5.2. Flow-pressure Relationships and the Vasomotor Response 
Changes in hemodynamics require a coordinated vasomotor response from both the large 
extracranial arteries, specifically the vertebral and internal carotid arteries, and the pial vessels 
(1). Two, reciprocal terms have been used to quantify the vasomotor response: conductance 
describes the relationship of flow over pressure, and has been used interchangeably with its 
reciprocal, resistance (14). However, these terms should not be used liberally and 
interchangeably without regard to knowing how vasoactive substances, activation of the 
baroreflex, or stimulating the sympathetic nervous system affect the flow-pressure relationship, 
as using one term over the other can lead to erroneous conclusions (14). Furthermore, it has been 
suggested that conductance is the correct measure to use when there is a need to describe the 
flow-pressure relationship in regards to changes in vascular tone, changes in perfusion pressure 
gradient, or changes in mean arterial pressure as a result of the baroreflex or exercise-induced 
vasoconstriction (13-15). 
In terms of cerebrovascular flow-pressure relationships, Claassen makes a sound case for 
the use of the cerebrovascular conductance index (CVCI) vs the cerebrovascular resistance index 
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(12). Particularly, he argues using resistance, instead of conductance, would lead to difficulties in 
data interpretation, especially when considering numbers resulting from increased 
hemodynamics. For example, vasodilation during low resistance and high brain blood flow 
would reflect a large increase in CVCI and a small decrease in the cerebrovascular resistance 
index, so an analysis of this vasomotor response relying on the small decrease in cerebrovascular 
resistance would be incorrectly interpreted as a small increase in vasodilation. Thus, Claassen 
argues the use of the CVCI as a marker of the cerebrovascular response to stress because 
vasomotor testing increases hemodynamics (12), and it may be a useful marker of 
cerebrovascular aging because older adults have a 30% lower CVCI value compared to younger 
adults (10). 
 
1.5.3. The Cerebrovascular Response to Physiological Stress 
 The cerebrovascular response to physiological stress varies by age and is not linear. 
MCAv reactivity and CVCI reactivity to hypercapnic gas showed 35% lower MCAv and 53% 
lower CVCI in older adults compared to young adults (10).  A recent study looked at healthy 
young adults and their MCAv and CVCI response to 3% and 6% CO2 hypercapnic gas challenge. 
In response to 3% CO2, there was an absolute percent increase of 10% in MCAv and a 17% 
absolute percent change decrease in CVCI. In response to 6% CO2 challenge, there was an 
absolute percent change increase of 52% and an absolute percent decrease of 25% CVCI 
compared. Hence the MCAv and CVCI response to CO2 increase is not linear, although MAP 




1.5.4. The Cerebrovascular Response to Exercise 
Challenge to the cerebrovasculature, such as breath holding, can produce a hemodynamic 
response that is different across the spectrum of brain aging (82). Aerobic exercise provides an 
alternative stimulus to breath-holding and hypercapnic gas, because exercise provides a 
challenge to cerebrovascular function with changes in carbon dioxide output and blood pressure 
(83, 84). One of the advantages of acquiring data with TCD ultrasound versus a MRI imaging is 
that participants can engage in physical activity real-time during the assessment. Hence, there is 
a growing body of work looking at exercise-induced changes in hemodynamics measures. The 
work of Ainslie and colleagues showed that MCAv mean is maintained during hypoxic (80% 
arterial oxygen saturation) rest and during hypoxic cycling exercise compared to normoxic rest 
and exercise (66). Further work from this group showed age differences in MCAv mean changes 
during exercise. In a comparison between 14 older adults and 21 young adults, young adults had 
almost a 100% greater MCAv mean increase when going from rest to 50% of peak oxygen 
uptake (VO2peak) (28% younger adults vs 15% older adults) (85). This has been corroborated by 
other work which has shown that exercise-induced MCAv mean remains lower in older adults 
compared to younger adults across submaximal and maximal exercise (8, 86, 87). 
Our understanding of exercise-induced CVCI is not as well understood. In one study 
comparing MCAv-centered outcomes between older and younger adults during maximal and 
submaximal exercise (8), the CVCI had different trajectories between the two groups. In young 
adults, the CVCI increased at submaximal levels over rest, then went below resting levels at 
maximal intensity. In older adults, the CVCI did not change significantly from resting levels at 
submaximal level, but, similar to the younger adults, the CVCI fell below resting level at 
maximal intensity. Further, the CVCI was significantly lower in all adults at rest and during both 
17 
 
exercise intensities. In contrast, a previous study showed no differences in CVCI at rest and low 
intensity exercise between age groups, but older adults had lower CVCI at moderate intensity 
(86). One possible explanation between the two studies may be the age of the older adults. Closer 
inspection of the TCD indices between the two studies shows a resting MCAv mean percent 
difference of 48% and a resting CVCI percent difference of 56% values between the two older 
adult groups. Although there were only 19 older adults in the two studies, such stark differences 
suggests that in less than 10 years of aging, cerebrovascular function can decline by about 50%. 
 
1.6. Cerebrovascular Function and Cognition 
1.6.1. MCAv and Cognitive Domains 
The MCAv has been used to study to the link between cerebrovascular function and 
cognition, particularly in tasks involving planning, language, and visuospatial abilities in healthy 
individuals (88-91). Strong associations between the MCAv mean and cognition has also been 
reported across a variety of neurological conditions, such as chronic traumatic brain injury (TBI), 
stroke, epilepsy, and dementia (92-95). In a study of boxers versus controls, boxers had lower 
cognitive performance, lower MCAv mean, and diminished CVRC, suggesting that MCAv-
centered outcomes may be sensitive enough to capture the cerebrovascular deficits associated 
with chronic TBI (92). The MCAv mean has been used to assess and predict language 
lateralization in epilepsy and recovering stroke patients. In the former case, MCAv mean was 
assessed in people with epilepsy undergoing a word test (96); in the latter, MCAv mean in the 
hemisphere ipsilesional to the stroke lesion was a predictor of recovery from aphasia(94). In the 
Rotterdam Study, cognitively normal participants had greater MCAv mean, which was related to 




1.6.2. MCAv and Executive Function 
Executive function (EF) is an umbrella term which encompasses various cognitive skills, 
such as task switching, planning, inhibition, working memory, sustained attention, and selective 
attention (97). EF deficits can show up early in AD (98), and there is evidence suggesting EF 
deficits precede memory deficits prior to the diagnosis of AD (preclinical phase) (99, 100). The 
EF deficits can manifest to impact daily functioning, as a meta-analysis of executive function 
and AD suggested that the moderate relationship between EF and activities of daily living 
(ADLs) explains why AD patients with executive dysfunction have trouble with day-to-day 
living (101). However, lesions in the frontal cortex, particularly in the frontal-striatal tracts 
underlying EF, develop in conjunction with atrophy of medial temporal areas, which underlie 
memory (102). Hence, capturing the early decline of executive function is important in 
identifying the time window of burgeoning memory impairment in AD development.   
 The interplay between MCAv and EF is not completely understood. There is some 
research which supports the role of decreased MCAv in the development of executive 
dysfunction. For instance, in Bailey and colleagues’ work comparing active professional boxers 
to controls, boxers showed impaired cerebrovascular function, in particular lower MCAv 
reactivity to hypercapnic gas. Moreover, boxers had marked EF performance deficits across three 
tests. Specifically, the boxers had a 36% slower response time in Stroop performance, a 38% 
slower completion time in the Trail Making Test A (TMTA), and a 43% slower completion time 
in the Trail Making Test B (TMTB) (92).  However, in Lucas’ study, the authors reported that 
MCAv was significantly inversely related to Stroop performance (r = -0.69, p < 0.001), 
suggesting that EF performance, particularly an increase in attentional interference, coincides 
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with increased brain blood flow (103). Therefore, two contradictory interpretations can be 
made: The Bailey interpretation is the greater the MCAv, the better the cognitive outcome, but 
the Lucas interpretation is the lower the MCAv, the better the EF performance. Thus, there is a 
need to better characterize the relationship between cerebrovascular function, particularly 
MCAv, and EF.   
 In chapters 2 and 4, we use different iterations of the widely-used TMT to examine the 
relationships between MCAv-centered indices and EF in nondemented aging (chapter 2) and 
preclinical AD (chapter 4). The TMTA and TMTB are two iterations of a timed test. The TMTA 
requires takers to draw lines between consecutively numbered circles. The TMTB requires takers 
to draw lines between consecutively numbered and lettered circles. Hence, the TMTA tests 
number recognition, visual scanning, processing speed, and number sequencing. The TMTB, in 
addition, tests set shifting and cognitive flexibility in handling multiple stimuli simultaneously. 
The raw TMTA and TMTB scores can be manipulated to derive other scores. One iteration is the 
delta TMT (TMTD), the time difference between TMTA and TMTB. The TMTD assesses set 
shifting ability, which decreases as a function of age (104). The TMTD score may provide a 
more accurate EF score (105) by accounting for the performance differences due to arm speed, 
simple sequencing, visual scanning, and processing speed (104). Another derived iteration score 
is the TMT ratio score (TMTR). The TMTR is calculated by dividing the raw TMTB score over 
the raw TMTA score. This score reflects the cost of set shifting. Specifically, an increase in 
TMTR is associated with increases in response time to switching between tasks, due to the 
inability to suppress attention from a previously engaged task (106). Higher TMT z-scores and 
lower TMTD and TMTR scores are indicative of better EF performance, but there is no 




1.6.3. White Matter Lesions and Brain Blood Flow 
 Tzourio and colleagues reported on the relationships between brain blood flow velocity 
outcomes and grades of WMLs (107). The Epidemiology of Vascular Aging study was a 
population-based longitudinal study aimed at studying cognitive decline and vascular aging. 
Researchers recruited 1,389 adults ages 59-71 years and followed over a period of four years 
(108). Of these participants, 628 participants over the age of 63 had their resting MCAv mean 
recorded at rest and underwent an MRI scan in a 1.0 T scanner. They reported that higher 
quartiles of WMLs had lower MCAv mean (107), thereby suggesting that diminished MCAv  is 
a risk factor for WMLs. Having captured bilateral MCA signals in a large number of older adults 
is a strength of this study. However, the investigators were unable to obtain bilateral MCA 
signals in 206 participants. The age and WMLs differences between these participants and the 
628 participants should be noted. Specifically the participants with missing bilateral MCA 
signals were significantly older and significantly had more severe WMLs. They did not report 
how many of the participants had useable MCA signal from just one side. Therefore, they missed 
an opportunity to establish the relationships between unilateral MCAv and WMLs. A second 
limitation was that the MCA signal was obtained at supine, which produces a less reliable 
measurement compared to a seated position (77). 
 Tzourio’s work is contradicted by recent work from Shim and colleagues, which 
suggested no relationship between TCD measures and WMLs (82). In this 2015 study, 67 AD 
patients, 75 MCI patients, and 52 controls were recruited to assess how hemodynamics related to 
cognition. Measurements included the MMSE and CDR; WMLs, graded on severity; and TCD-
obtained MCAv mean and breath-holding-induced CVRC. Initially, there were significant 
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differences between the groups in TCD measures, such that the AD group had lower MCAv 
mean and lower CVRC than both controls and MCI. However, after adjusting for age, education, 
and WML severity, there were differences between the groups in MCAv mean. After the 
adjustment, the AD group had significantly reduced CVRC compared to controls and MCI. 
Regression analysis showed that WMLs were not significant indicators of MCAv mean or 
CVRC, contradicting the findings of Tzourio and colleagues. Thus, the relationships between 
WMLs and MCAv-centered indices are not fully understood.  
 In chapter 3, we present our work regarding the relationships between cerebrovascular 
function, WML burden, and cognition. Although WML burden is used as a marker for 
cerebrovascular aging, not all WMLs are caused by vascular dysfunction. We set out to show 
that MCAv-centered outcomes and WML burden were related, and then followed up with an 
analysis to determine whether MCAv-centered outcomes or WML burden better predicted global 
cognition. Hence, the work presented in chapter 3 provides needed insight as to whether an 
alternative marker to WML burden can better characterize the relationship between 
cerebrovascular function and cognition. 
 
1.7. Applications and Significance 
 This work has important implications to brain aging, and we aimed to expand upon the 
relationships cerebrovascular function, as measured by MCAv, CVCI, and CVRC, has with 
cognitive function, brain structural integrity, and preclinical AD neuropathology. Compared to 
the existing literature focused on neuronal mechanisms and health, less is known regarding 
exercise, cerebrovascular function, and cognition, specifically executive function, and how they 
relate to each other in nondemented aging. In chapters 2 and 4, we aimed to untangle these 
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relationships by studying MCAv mean responses to moderate intensity exercise. The work in 
chapters 2 and 4 characterizes the relationship between TCD outcomes and EF because EF 
deficits may precede memory deficits during pathological brain aging (99, 100). We looked at 
the relationships between exercise-induced cerebrovascular function indices (MCAv, CVCI and 
CVRC) with cognitive scores, providing us the opportunity to assess whether MCAv, CVCI, and 
CVRC measures could be used as markers for cognitive aging in nondemented aging (chapter 2) 
and preclinical AD (chapter 4). In chapter 3, we aimed to characterize the relationship between 
MCAv mean, CVCI, and CVRC with white matter lesion (WML) burden, a cerebrovascular 
biomarker which does completely correspond to cerebrovascular function, but has been 
nonetheless used to characterized cerebrovascular dysfunction across the spectrum of aging. In 
chapter 4, we discuss new findings pertaining to the role cerebrovascular function has in 
preclinical AD, which is defined as individuals having elevated levels of the protein, β-amyloid. 
Hence the work in chapter 4 sheds light on how amyloid load relates to MCAv mean, CVCI, and 
CVRC. In total, the work presented here lays the foundation to support using a physical 
challenge such as exercise may have indices as biomarkers across the spectrum of nondemented 
aging, which could have impact on how we understand stroke, TBI, and dementias. 
   
1.8. Aims 
In summary, the literature is lacking important information regarding how to preserve 
cerebrovascular function throughout the course of aging. Preserving and enhancing brain blood 
flow may be the key. Yet, before therapeutics can be developed, the field must first develop 
biomarkers sensitive to changes in cerebrovascular function and cognition. In regards to 
combatting Alzheimer’s, as the evidence against the Amyloid Cascade Hypothesis accumulates, 
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it is imperative we develop a biomarker that is not totally dependent on amyloid load, yet robust 
enough to distinguish between nondemented older adults with/without elevated levels of 
amyloid. The main goal of this project is to better understand whether measures of 
cerebrovascular function indices at rest and during exercise are related to cognition and brain 
structural integrity (WML burden) during cognitively normal aging. To accomplish this task we 
had 3 aims via which we sought to answer our primary hypotheses (H).  
 
Aim 1: To determine whether cerebrovascular health is related to cognition in 
cognitively normal older adults. 
We will study n = 37 older adults without cognitive impairment and who have completed 
cognitive testing on the Uniform Data Set (UDS). We will study their cerebrovascular function 
using TCD and beat-to-beat blood pressure. We will obtain two measures of cerebrovascular 
health, mean middle cerebral artery velocity (MCAv mean) and mean cerebrovascular 
conductance index (CVCI), which describes the MCAv mean in relation to mean arterial 
pressure (MAP) (12).  We first hypothesized that resting MCAv mean and CVCI would be 
positively correlated to an age, sex and education adjusted TMTB score (TMTB-Z), our measure 
of EF (H1). We will calculate percent change in MCAv mean (i.e., the CVRC) and CVCI 
between rest and moderate intensity exercise for analysis of our secondary hypotheses. We 
hypothesize that exercise-induced CVRC and CVCI percent change would have positive 
relationships with TMTB-Z (H2) and negative relationships with the secondary EF measures, 




Aim 2: To determine whether white matter lesion burden is related to the 
cerebrovascular function in cognitively normal older adults.  
Although WML burden is used as a marker for cerebrovascular aging, not all WMLs are 
caused by vascular dysfunction. First, we set out to show that resting and exercise-induced 
cerebrovascular function and WML burden were related because inducing hemodynamic 
changes may elucidate the relationship between perfusion and WMLs (82). Second, we will 
conduct a secondary analysis to determine whether cerebrovascular function or WML burden 
better predicted global cognition (Mini-Mental State Exam z-scores).  Finally, we set to 
determine if resting and the exercise-induced cerebrovascular function can predict WML burden 
and determine if exercise-induced cerebrovascular functions are better predictors of global 
cognition than WML burden. Using the same cohort in Aim 1, we hypothesize that WML burden 
will be negatively related to our resting and exercise-induced measures of cerebrovascular 
function, MCAv mean, CVRC, and CVCI (H4). Further, we expect both resting and exercise-
induced cerebrovascular function measures to predict WML burden (H5). Finally, we expect 
exercise-induced cerebrovascular function to be better predictors of MMSE z-scores than WML 
burden (H6).  
 
Aim 3: To determine whether the cerebrovascular function is altered by the 
presence of β-amyloid in cognitively normal older adults. 
For this aim, we will enroll 34 cognitively normal older adults who have undergone 
Amyvid PET imaging and have been characterized as having elevated (β+, n = 17) or non-
elevated (β+-, n = 17) cerebral β-amyloid levels. We will match these adults by age (+ 3 years), 
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gender, and cardiac risk disease classification (moderate or high risk). Participants will have 
cerebrovascular TCD outcomes recorded at rest and during moderate intensity exercise. We will 
determine if CVCI is altered in older adults with elevated levels of cerebral β-amyloid compared 
to older adults with non-elevated levels of cerebral β-amyloid. We hypothesize that β+ older 
adults will show lower MCAv mean and lower CVCI compared to β- older adults (H7). Second, 
we expected the β+ group to have lower global cognition scores and executive function (H8). 
Finally, we expected exercise-induced changes in CVRC and CVCI would positively relate to 
better scores of EF, specifically with higher TMTB z-scores (TMTB-Z), lower TMT delta scores 
(TMTD), and lower TMT ratio scores (TMTR) (H9). As we progressed through the project for 
this aim, we decided to examine a larger group (vs matched pairs) and examine CVRC and 




Chapter 2  
The Partial Relationships Between Cerebrovascular Function At Rest and During Exercise 





The aging brain is accompanied by decreases in cerebrovascular function and executive 
function (EF). We lack a thorough understanding between cerebrovascular function and 
executive function during aging. Using beat-to-beat transcranial Doppler ultrasound, we set out 
to elucidate the relationships between resting and exercise-induced cerebrovascular function and 
EF in a cohort of 45 nondemented older adults over 65. We expected our resting and exercise-
induced cerebrovascular measures would positively correlate with better EF performance. The 
cerebrovascular measures were the MCAv mean, cerebrovascular conductance index (CVCI), 
and cerebrovascular reserve capacity (CVRC). We used the Trail Making Test A and B (TMTA, 
TMTB) to obtain three EF scores, the TMTB z-score (TMTBZ), the delta score between TMTB 
and TMTA (TMTD), and the TMTB:TMTA ratio score (TMTR). There were no relationships 
between the TMTBZ and resting and exercise-induced cerebrovascular function. Spearman 
correlations showed a direct relationship between resting MCAv mean and TMTR (r = 0.314, p = 
0.018) and an inverse relationship between CVRC and TMTD (spearman r = -0.293, p =0.025) 
but no other cerebrovascular function measures were significantly related to EF. These two 
findings suggest resting MCAv mean and a greater cerebrovascular reserve correlates to better 
EF using the TMTR and TMTD, respectively. However, because no relationships were found 
between resting and exercise-induced cerebrovascular function and the TMTBZ score, we cannot 
generalize these results as applicable to other nondemented, elderly populations. Further 
characterization of the relationships between exercise-induced cerebrovascular function and 






 One of the age-associated risks with profound implications in both healthy and 
pathological brain aging is decreased cerebral perfusion, or brain blood flow hemodynamics. The 
average yearly brain blood flow decrease during normal aging is initially estimated to be 0.05%. 
More recent studies suggest that the decrease is between 0.78% and 1.2% per year (30, 31). In 
contrast, there is an estimated 6.2% yearly decrease in global brain blood flow in older adults 
with cognitive decline and dementia (32). Further, decreased hemodynamics is as an important 
factor in a multitude of brain diseases such as Parkinson’s disease, Huntington’s disease, and 
stroke (25-28). Through multiple neuroimaging modalities, we have gained important insights 
into how cerebrovascular function is impacted across the continuum of aging. For instance, the 
use of arterial spin labeling imaging has shown that impairments in regional brain blood flow can 
be a distinguishing factor between nondemented older adults, those with mild cognitive 
impairments, and those with Alzheimer’s disease (109-111). This discrepancy in brain 
hemodynamics has given us key insight into the potential contributions of the vasculature to 
normal and pathological aging (16, 112-115). 
Transcranial Doppler (TCD) ultrasound is used to assess brain blood flow velocity at rest, 
during hypercapnic conditions and during exercise. In a comparison between older adults (n = 
14) and young adults (n = 21), young adults had almost a 100% greater MCAv mean increase 
over older adults when going from rest to 50% of peak oxygen uptake (VO2peak) (85).  This has 
been corroborated by other work which has shown that exercise-induced MCAv mean remains 
lower in older adults compared to younger adults across submaximal and maximal exercise (8, 
86, 87). Hence, this suggests that the cerebral vascular reserve capacity (CVRC), or ability to 
increase blood flow in response to a stimulus such as exercise (80), declines with aging. Another 
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MCAv-centered outcome is the cerebrovascular conductance index (CVCI), which describes the 
brain’s flow-pressure relationship and has been used to quantify the cerebrovascular vasomotor 
response to stress, such as exercise (8, 12, 62, 86). Similar to the MCAv, the resting, 
hypercapnic-induced, and exercise-induced CVCI is significantly lower in older adults compared 
to younger adults (10, 86) largely due to the increased in mean arterial blood pressure.  
Cerebrovascular function, in general, may underlie executive dysfunction (EF) 
development during aging (116). The relationship between cerebrovascular function using 
MCAv through TCD ultrasound and EF decline is not clear. For instance, in Bailey and 
colleagues’ work comparing active professional boxers to active athletes not engaging in 
sparring activities, boxers showed impaired cerebrovascular function in response to a 
hypercapnic condition (given a higher CO2 gas mixture). In addition to impaired cerebrovascular 
function, those categorized as boxers demonstrated worse performance on EF tests with a 36% 
slower response time in Stroop performance, a 38% slower completion time in the Trail Making 
Test A (TMTA), and a 43% slower completion time in the Trail Making Test B (TMTB) (92).   
 Studies measures such as MCAv and the TMT have provided insight into EF and brain 
hemodynamics in stroke and hypertension, suggesting the roles of brain injury and blood 
pressure in the development of executive dysfunction (117, 118). However, to date, we do not 
have a clear understanding of how hemodynamic characteristics influence EF during normal 
aging. Elucidating how both resting and exercise-induced MCAv-centered measures relate to EF 
may provide additional insight regarding cerebrovascular function in individuals at risk for 
pathological brain aging. The purpose of this study was to investigate the relationship between 
resting and exercise-induced MCAv-centered outcome measures and EF in healthy, non-
demented older adults. The MCAv-centered outcome measures were MCAv mean, 
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cerebrovascular conductance index (CVCI; MCAv mean/MAP), and cerebrovascular reserve 
capacity (CVRC) which was the percent change in in MCAv mean from rest to exercise. We 
collected TMTA and TMTB scores, and calculated multiple TMT score iterations to get indices 
of EF performance. Our primary EF measure was an age, sex, and education adjusted TMTB z-
score (TMTBZ) (119). Secondary EF measures were the delta TMT score (TMTD, calculated as 
TMTB-TMTA) (105) and TMT ratio score (TMTR, calculated as TMTB/TMTA) (106). We 
hypothesized that resting MCAv mean and CVCI would positively correlate to TMTBZ. We 
calculated percent change in MCAv mean (the CVRC) and CVCI between rest and moderate 
intensity exercise. We hypothesized that greater exercise-induced CVRC and CVCI percent 
change would relate to better performance on the EF scores, specifically higher TMTBZ scores 




 Older adults were recruited from the KU Alzheimer’s Disease Center’s Alzheimer’s 
Prevention Program from August 2014 to September 2016. Inclusion criteria were age over 65 
years, classification as cognitively normal/nondemented with a Clinical Rating Score = 0, 
sedentary or underactive lifestyle, and completion of Amyvid PET and MRI scans. Exclusion 
criteria were DSM-IV defined drug or alcohol abuse within the prior 2 years, clinically 
significant depression or anxiety, insulin-dependent diabetes, myocardial infarction or symptoms 
of coronary artery disease within the prior two years, acute decompensated congestive heart 
failure or class IV heart failure, major orthopedic disability, inability to exercise, inability to 
travel to the KUMC Research in Exercise and Cardiovascular Health (REACH) laboratory, and 
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inability for researchers to obtain the MCA signal from the transcranial window. Individuals who 
met the inclusion criteria provided institutionally approved written informed consent.  
 
2.3.2. Cerebrovascular Function Assessment 
 We used an experimental protocol similar to previously published work (86). This 
protocol captures MCAv mean and mean arterial pressure (MAP) for every cardiac cycle over an 
eight-minute rest period and during eight minutes of steady state moderate intensity exercise.  A 
ROBOTC2MD robotic TCD headset (Multigon, White Plains, NY)  was placed on the head and 
the ultrasound probes (2Hz) were used to capture the MCA signal;  a Finometer Pro finger 
plethysmography system (Finapres Medical Systems, Amsterdam, Netherlands) was placed on 
the left brachial arm and left middle finger, to record beat-to-beat MAP; a Capnocheck 9400 
capnograph (Smiths Medical, St. Paul, MN) and cannula was used to measure breath-by-breath 
end-tidal CO2  (ETCO2); and a 5-lead electrocardiogram (EKG) (CardioCard, Nasiff Associates, 
Central Square, NY) was placed according to appropriate anatomical marks to collect heart rate.   
 
2.3.2.1 Set Up. Figure 1 shows the experimental set up. Once EKG leads were placed, 
participants were instructed to sit upright on the NuStep T5XR recumbent stepper (NuStep, Inc., 
Ann Arbor, MI), and extend out both their arms to the side onto tables. The TCD headset, 
Finapres left arm and left finger cuff, capnograph nasal cannula, and Tango M2 right arm 
brachial cuff (SunTech Medical, Inc., Morissville, NC) were placed on the participant. Before 
onset of recording, the Finapres values were compared to the Tango automated blood pressure 
cuff to ensure accurate values with long-term recording (120). If the difference between Finapres 
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and Tango values were greater than 15 mm Hg, the Finapres finger cuff was removed then 
repositioned, until the difference was below the recommended 15 mm Hg (121). 
 
 
Figure 1. Experimental Set Up. Beat-to-beat assesment depends on the synchronization of 
mutliple pieces of equipment. A= Cardiocard EKG software; B = TCD output; C = Finapres 
finger cuff; D = Finapres brachial cuff; E = Multigon TCD headset; F = nasal cannula; G = 
NuStep T5XR recumbent stepper; H = Tango M2 brachial cuff; I = Tango M2 module; J = 
Capnograph; K = Finapres module; L = Matlab collection program. 
 
2.3.2.2. Resting and Exercise Recordings. After completion of set up, participants were 
instructed to remain seated, breathe through the nose, fix their gaze forward, and refrain from 
talking and movement. Then eight minutes of data were recorded.  After rest, participants 
completed one bout of moderate intensity exercise. Moderate intensity exercise was defined as 
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an exercise target zone between 40%-60% heart rate (HR) reserve (122). Age predicted HR 
maximum (220-age) was used in the calculation.  
THR = [(age-predicted maximum HR− resting HR) × % Exercise Intensity)] + 
resting HR 
 Participants were instructed to use only their legs during the exercise session. As 
participants pedaled at a cadence of 90-100 steps per minute, the resistance was increased until 
the THR was reached and maintained for one minute then recording commenced. Beat-to-beat 
values were recorded for eight minutes during exercise. Upon completion of eight minutes of 
exercise, participants cooled down for one minute at 15 watts.  
 
2.3.2.3 Data Collection and Computations. Analog signals were fed through an analog-
to-digital signal converter (NI USB-6212, National Instruments Corporation, Austin TX), 
collected and displayed in real time with a custom MATLAB program (The MathWorks, Inc., 
Natick, MA).  We collected an R-wave trigger signal, MCAv and MAP at 500 Hz (Figure 2).  
Beat-to-beat Finapres and TCD values were calculated via integration of each cardiac cycle and 
then dividing the integral by length of the cardiac cycle. A custom MATLAB post-processing 
program computed our primary cerebrovascular outcome variables. Percent changes in the 
primary cerebrovascular measures were calculated. Percent change was calculated using the 
formula: 
Percent Change X = (|(X at moderate intensity exercise – X at rest)/X at rest| x 100) 
where X denotes a primary cerebrovascular measure. Percent change was calculated for ETCO2, 





Figure 2. Example of Data Acquisition Using Custom MATLAB Data Collection Program. 
Finapres (red line) and TCD (green line) signals were aligned to onset of a trigger signal based 
on detected R-waves (blue line) for each beat over eight minutes of recording. A processing 
script converted the analog voltage (Y-axis) into appropriate physiological units for mean arterial 
pressure and mean MCA velocity. 
 
2.3.3 Executive Function 
 As part of the Alzheimer’s Prevention Program, our study participants underwent 
cognitive testing by a trained psychometrician and completed the Uniform Data Set (UDS) 
version 2.0 (123). The standard battery consists of multiple cognitive tests, including Mini-
Mental State Exam, Immediate and Delayed Logical Memory, Digit Span Forward/Backward, 
Animal and Vegetables Category Fluency, WAIS- Digit Symbol, Boston Naming, and the Trail 




 2.3.3.1 Trail Making Tests. The TMTA and TMTB are timed tests and assess different 
aspects of executive function. The TMTA requires takers to draw lines between consecutively 
numbered circles; in the TMTB, takers draw lines between consecutively numbered and lettered 
circles. Hence, the TMTA tests number recognition, visual scanning, psychomotor speed, and 
number sequencing. The TMTB, in addition, tests set shifting and cognitive flexibility in 
handling multiple stimuli simultaneously. Delta TMT (TMTD) is the time difference between 
TMTA and TMTB, and it reflects set-shifting ability, which decreases as a function of age (104). 
Raw TMTB test scores for each participant were normalized into our primary cognitive measure, 
TMTB Z-scores (TMTBZ), adjusted for age, sex, and education according to previously 
published methods (119).  
In addition to the TMTBZ, we calculated secondary TMT measures using both the 
TMTA and TMTB raw scores. We calculated the TMT delta score (TMTD) by subtracting the 
raw TMTA score from the raw TMTB score. The TMTD score may provide a more accurate 
measure of executive function (105) by accounting for the performance differences due to arm 
speed, simple sequencing, visual scanning, and psychomotor speed (104). Finally, the TMT ratio 
score (TMTR), was calculated by dividing the raw TMTB score over the raw TMTA score. This 
score reflects the cost of set-shifting. Specifically, an increase in TMTR is associated with 
increases in response time to switching between tasks, due to the inability to suppress attention 






2.3.4 Data Analysis 
 Analyses were completed using SPSS version 23 (SPSS, version 23, IBM Corporation, 
Armonk, NY). For our first step in testing our hypotheses, we assessed homogeneity of variance 
and normality using Levene’s test for equality of variance and the Shapiro-Wilk test, 
respectively.  One-tailed Pearson correlation was used to assess the relationship between two 
normally distributed variables. One-tailed, non-parametric Spearman correlation (124) was used 
for data that violated normality or homogeneity of variance.  We conducted paired samples T-
tests to assess differences between rest and moderate intensity exercise. When assumptions of 
normality and homogeneity variance were violated, we used non-parametric related samples 




 We recruited 64 older adults from the Alzheimer’s Prevention Program into our study. 
We successfully insonated the MCA and obtained the MCAv signal in 51 (79.7%) participants. 
We were unable to use data from an additional 6 participants due to unattainable Finpares and 
capnograph signal. Specifically, one participant did not have a useable Finapres signal both at 
rest and during exercise; one participant did not have a useable capnograph signal at rest and 
during exercise; two participants did not have a useable capnograph signal during exercise; and 
two participants only completed rest Twenty-one participants were on blood pressure 
medications, and fourteen participants had resting blood pressures above the normotensive range 
(140/90 mm Hg) (125). Table 1 depicts the descriptive statistics pertaining to participant 
characteristics, cerebrovascular function, and executive function scores. The mean raw TMTA 
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and TMTB scores used for calculation of our EF scores were, respectively, 29.1 + 10.7 s and 
73.8 + 31.5 s.  
Measure Mean + SD Range [minimum, maximum] 
Age, years 71.3 + 5.1 21  [65,86] 
BMI, kg/m2 26.5 + 4.5 22.9 [18.6, 42.7] 
Education, years 16.9 + 2.8 13 [12,25] 
TMTBZ 0.081 + 0.77 4.3 [-2.64, 1.61] 
TMTD, s 44.8 + 27.0 135 [13, 148] 
TMTR 2.63 + 0.95 5.32 [1.48, 6.80] 
Resting MCAv mean, cm*s-1 48.4 + 9.2 39.7 [25.7, 65.4] 
Resting CVCI, cm*s-1 *mm Hg-1 0.668 + 0.18 0.76 [0.365, 1.13] 
Table 1. Descriptive Statistics of Participant Characteristics, Cerebrovascular Function, 
and Executive Function Scores. BMI= body mass index; TMTBZ = Trail Making Test B z-
score; TMTD = Trail Making Test Delta score; and TMTR = Trail Making Test Ratio score; 
MCAv = middle cerebral artery velocity; CVCI = cerebrovascular conductance index. 
 
 Shapiro-Wilk tests were used to determine normality. Resting EtCO2 (p = 0.801), resting 
MCAv mean (p = 0.544), and resting CVCI (p = 0.179) were normally distributed, but not 
resting MAP (p = 0.004). With exercise, ETCO2 (p = 0.014) and MAP (p < 0.001) were not 
normally distributed but MCAv mean (p = 0.632) and CVCI (p = 0.184) were normally 
distributed. Percent change values for MAP (p = 0.390) were normally distributed, but not the 
percent change values for ETCO2 (p < 0.001) and CVCI (p = 0.039). The CVRC was not 
normally distributed (p = 0.001). The primary EF measure, TMTBZ, was not normally 
distributed (p = 0.003). Neither of the secondary EF measures, TMTD and TMTR, were 





2.4.1. Resting Cerebrovascular Function & Executive Function 
 We report no relationships between the TMTBZ and resting cerebrovascular function, but 
we found one relationship between resting cerebrovascular function and a secondary EF 
measure, the TMTR. Table 2 shows the relationships between resting and exercise-induced 
cerebrovascular function and executive function scores. The relationships between resting 
cerebrovascular function and our primary EF scores is shown in Figure 3. Figure 3A shows the 
rank MCAv mean and rank TMTBZ.  Spearman correlation analysis did not reveal a significant 
positive correlation between MCAv mean and TMTBZ (spearman r = -0.070, p = 0.325). Figure 
3B shows the relationship between rank CVCI and rank TMTBZ. Spearman analysis revealed a 
small positive, but non-significant relationship between CVCI and TMTBZ (spearman r = 0.043, 
p = 0.389). No significant relationships were found between cerebrovascular function and 
secondary EF measures, except for TMTR. Figure 4 shows the significant and positive 
relationship between rank MCAv mean and rank TMTR (spearman r = 0.314, p = 0.018). 
  Executive Function Measure  
    
Cerebrovascular Function 
 Outcome  TMTBZ TMTD TMTR 
Resting MCAv mean 
r = -0.070,  
p = 0.325 r = 0.147, p = 0.167 r = 0.314, p = 0.018 
Resting CVCI 
r = 0.043,  
p = 0.389 r = -0.008, p = 0.479 r = r = 0.182. p = 0.116 
CVRC 
r = 0.162, 
 p = 0.144 r = -0.293, p = 0.025 r = -0.177, p = 0.122 
Percent Change CVCI 
r = -0.120, 
 p = 0.216 r = 0.163, p = 0.142 r = 0.073, p = 0.317 
Table 2. Relationships between Resting and Exercise-induced Cerebrovascular Function 
and Executive Function Scores. Spearman correlations between cerebrovascular function and 
executive function. MCAv = middle cerebral artery velocity; CVCI = cerebrovascular 
conductance index; CVRC = cerebrovascular conductance index; TMTBZ = Trail Making Test 













Figure 3. Relationship between Resting Cerebrovascular Function and Trail Making Test 
B Z-scores.  A) This plot depicts the relationship between TMTBZ ranks against the resting 
MCAv mean ranks (spearman r = -0.070, p = 0.325). B) This plot depicts the relationship 





Figure 4. Relationship between Resting Cerebrovascular Function and Trail Making Test 
Ratio Scores. This scatterplot shows the significant and positive relationship between resting 
rank MCAv mean and rank TMTR (spearman r = 0.314, p = 0.018). 
 
 
2.4.2. Exercise-induced Cerebrovascular Function and Executive Function 
 We report no relationships between the TMTBZ and exercise-induced cerebrovascular 
function, but we found one relationship between exercise-induced cerebrovascular function and a 
secondary EF measure, the TMTD. Table 3 compares the cerebrovascular function measures 






Measure Resting (+ SD)  Exercise (+ SD) Percent Change (+ SD) 
ETCO2, mm Hg 33.3 + 5.4 37.4 + 5.3 16.9 + 12.3  
MAP, mm Hg 74.2 + 12.3 104.7 + 22.6 41.8 + 22.6  
MCAv mean, cm*s-1 48.4 + 9.2  54.7 + 13.2 17.2 + 10.6 
CVCI, cm*s-1 *mm Hg-1 0.668 + 0.18 0.527 + 0.15 -21.4 + 14.8 
Table 3.  Primary Measures at Rest and during Moderate Intensity Exercise. ETCO2 = End-
tidal CO2; MAP = mean arterial pressure; MCAv = middle cerebral artery; CVCI = 
cerebrovascular conductance index.  
 
 Figure 5 shows the relationships between the exercise-induced cerebrovascular 
outcomes and the primary EF score.  Figure 5A shows the relationship between the rank CVRC 
(percent change in MCAv mean) and rank TMTBZ, which was positive, but non-significant 
(spearman r = 0.162, p = 0.144).  Figure 5B shows the relationship between rank percent change 











Figure 5.  Relationship between Cerebrovascular Function during Exercise and Trail 
Making Test B Z-scores.  A) Scatterplot of the TMTBZ ranks against the CVRC ranks (spearman r = 
0.043, p =0.389). B) Scatterplot showing the relationship between TMTBZ ranks and percent change 
CVCI ranks (spearman r = -0.120, p = 0.216).   
 
 Spearman analysis of secondary EF scores did not show any significant relationships 
with exercise-induced cerebrovascular measures, except between CVRC and TMTD. Figure 6 
shows a significant and negative relationship between rank CVRC and rank TMTD (spearman r 





Figure 6.  Relationship between Cerebrovascular Reserve Capacity and Trail Making Test 
Delta Scores.  Scatterplot showing the relationship between TMTD ranks and CVRC ranks 
(spearman r = -0.293, p =0.025). 
 
2.5. Discussion 
 Decreases in brain blood flow and cognitive performance are features of the aging brain. 
Executive dysfunction may be prevented by addressing vascular risk factors (126), so it is 
plausible that identifying a marker at the interface of vascular function and brain function may 
prove useful in combatting age-related executive function (EF) decline. Since little is known 
concerning the relationships between cerebrovascular function and EF, we conducted an 
investigation to elucidate how cerebrovascular function relates to EF in nondemented older 
adults. Our overall aim was to determine if measures of resting cerebrovascular health and 
measures of exercise-induced cerebrovascular reserve could be used as markers of EF during 
nondemented aging. By studying MCAV-centered outcomes, we specifically tested whether 
resting cerebrovascular function and exercise-induced cerebrovascular function linked to EF 
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performance using three iterations of the widely-used Trail Making Test (part B z-score, 
TMTBZ; delta score, TMTD, and TMTA:TMTB ratio score, TMTR).  
Our data provides partial support for our hypotheses. Particularly, we have partial 
evidence that the Trail Making Test is related to resting and exercise-induced MCAv function, 
but is not related to resting or exercise-induced cerebrovascular conductance (CVCI). Further, 
our results suggest that MCAv has different relationships with EF performance depending 
whether the cerebrovasculature is at rest or is being challenged with exercise: higher resting 
MCAv relates to poorer EF performance, but higher exercise-induced CVRC relates to better EF 
performance.  Higher MCAv mean is seen in hypertension (127), and approximately half of our 
cohort was on blood pressure medications, and approximately 1/3 exhibited resting blood 
pressures above the normotensive range (125). Our results support one study which originally 
showed a relationship between hypertension and poor EF and also showed a link between greater 
cerebrovascular reserve and better TMT performance (128). Hence, our results may reflect the 
relationship between EF and hypertension’s mechanical effects on arterial function and/or 
endothleial function (114, 128). MCAv-centered measures are widely studied and have been 
used to assess EF performance, and we are the first to report a significant relationship between 
higher exercise-induced CVRC and better EF performance in a cohort of nondemented older 
adults using iterations of the TMT. However, the absence of significant relationships between all 
TMT iteration scores and resting MCAv and exercise-induced CVRC precludes the assertion of 
definitive, generalizable relationships between resting cerebrovascular function and exercised-
induced cerebrovascular reserve with EF. 
 
2.5.1. Resting Cerebrovascular Function & Executive Function 
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Contrary to our hypotheses, we report non-significant correlations between resting 
MCAv mean and resting CVCI with our primary EF measure, TMTBZ. Further analyses looking 
at resting cerebrovascular function and secondary EF measures showed one significant 
relationship, a positive correlation between resting MCAv and TMTR. This relationship was not 
expected and does not support our hypothesis.  This finding suggests higher resting brain blood 
flow velocity relates to poorer EF performance. Therefore, our results contradict three studies 
which link diminished cerebrovascular function to poorer EF performance, particularly on the 
TMTB (116, 129, 130). The first study looked at the relationships between arterial spin labeling 
perfusion imaging and cognition in 52 nondemented older adults. The TMT scores were adjusted 
for age and sex, and linear regression showed that global hypoperfusion and frontal cortex 
hypoperfusion related to poorer TMTB performance (116). The second study assessed perfusion 
via single photon emission computed tomography (SPECT) in older adults with mild cognitive 
impairment and adults with Alzheimer’s disease (130). These older adults were divided into a 
“poor” or “good” TMTB group based on raw TMTB scores. The poor TMTB group had 
hypoperfusion in the anterior cingulate cortex, caudate nucleus, caudate, and putamen, 
suggesting that regional cerebrovascular function underlies set-shifting performance deficits 
(130). The third study comes from recent work from the MOBILIZE Boston Study, which 
compared older adults with cognitive impairment to older adults without cognitive impairment 
(129). Older adults with cognitive impairment had significantly worse performance on the 
TMTB coupled with significantly lower MCAv mean and higher cerebrovascular resistance 
index (the mathematical reciprocal of the CVCI). Although the authors did not report TMTR or 
TMTD, calculation of both shows the cognitively impaired group had a TMTR of 2.35 and 
TMTD of 91.7s, compared to the cognitively normal group’s TMTR of 2.04 and TMTD of 61.8 
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s. Hence, in MOBILIZE Boston, the group with the lower brain blood flow velocity and lower 
cerebrovascular conductance had higher TMTR and lower TMTD scores, signaling worse EF 
performance and diminished cerebrovascular function. It is plausible that we did not see 
relationships between resting cerebrovascular function and all TMT iterations because lower 
MCAv mean is linked to higher white matter lesion burden (107), yet, our cohort had lower than 
average white matter lesion burden (data presented in Chapter 3) (131, 132). Thus, our cohort 
may not have been as impacted by the effects of age-related vascular risk factors, such as white 
matter lesions, which are known to deleteriously impact cerebrovascular function during aging 
(113).   
There are differences in TMT performance and resting cerebrovascular function between 
the cognitively healthy older adults in the MOBILIZE Boston Study and this current study. 
Specifically, we report a MCAv mean of 48 cm/s, whereas the MCAv mean reported in 
MOBILIZE Boston was 41 cm/s. This 7 cm/s difference between the two studies is almost 
double the MCAv mean difference between MOBILIZE Boston’s cognitively normal and 
cognitively impaired groups (difference = 3.6 cm/s). Therefore, our cohort of nondemented older 
adults may have better cerebrovascular function compared to the MOBILIZE Boston Study 
cognitively normal cohort. Pertaining to the EF performances, we report that the nondemented 
older adults had a TMTR of 2.63 and a TMTD of 44.8 s, juxtaposed to MOBILIZE Boston’s 
TMTR of 2.04 and TMTD of 61.8 s. Thus, at first glance, these numbers lead to a paradoxical 
conclusion: our cohort had better EF performance than the MOBILIZE Boston cognitively 
normal group if considering only the TMTD scores, but worse EF performance if considering 
only the TMTR scores. Resolution of this discrepancy relies on considering the raw TMTA and 
TMTB scores from both studies. We report a mean raw TMTA of 29.1 + 10.7 s and a raw TMTB 
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of 73.8 + 31.5 s, juxtaposed to MOBILIZE Boston’s raw TMTA score of 59.3 + 32.2 s and raw 
TMTB score of 121.1 + 79 s. Hence, our nondemented cohort has more than a 100% 
performance TMTA increase and almost a 40% TMTB performance increase over the 
MOBILIZE cognitively normal cohort. On average, our cohort’s age was seven years younger 
than the MOBILIZE Boston Study cohort, so to account for age, as well as gender and education, 
a crude calculation of the MOBILIZE Boston data yields a TMTBZ of -0.0567, which is lower 
than our reported TMTBZ of 0.081. Hence, via both closer inspection of the raw TMT scores 
and the use of a normative calculator, our nondemented older cohort had faster (better) 
performance on the TMT. Compared to normative TMT performance in the 70-74 age range 
(133), our TMTD score is roughly equivalent, and our TMTR score is slightly lower (better 
performance). However, our resting MCAv mean, 48.4 cm/s, is higher compared to previously 
reported resting MCAv means in nondemented aging, which has been reported in the mid-30s to 
mid-40s cm/s (134, 135). Thus, it is plausible that we did not find statistically significant 
relationships between resting cerebrovascular functions and all TMT scores due to greater brain 
blood flow velocity and better executive function observed in our cohort compared to previous 
reports. Conversely, one methodological difference may explain the difference between our 
resting MCAv mean average and previously reported MCAv mean averages. Our protocol 
captures beat-to-beat MCAv mean over an eight minute period, whereas previous work reported 
beat-to-beat MCAv mean averages in the  captured data over one to two minutes (85, 136). 
Hence, we recorded resting cerebrovascular function over a longer duration than previous work, 





2.5.2. Exercise-induced Cerebrovascular Function & Executive Function 
 The current data corroborates previous work in older adults in which moderate intensity 
exercise elicited changes in cerebrovascular function, particularly an increase in MCAv (84, 85) 
and a decrease in CVCI, compared to rest (84, 86). Previous work showed exercised-induced 
CVRC of 16% -21% in older adults (84, 85). A study by Fisher and colleagues showed an 
absolute CVCI percent decrease of 16.4% in older adults completing moderate exercise on a 
cycle ergometer accompanied by a 1 cm/s MCAv mean increase over rest (86). This drive in 
CVCI percent change was due to the 24% percent increase in MAP over rest, suggesting that the 
body maintains brain blood flow velocity in response to physiological stress by increasing 
arterial pressure (86). Therefore, our data suggests that the 42% increase in MAP is in response 
to the 17% increase in MCAv mean, resulting in a 21% exercise-induced decrease in CVCI. An 
exercise-induced decrease in CVCI indicates the possible vasoconstriction of cerebral vessels, a 
normal autoregulatory response needed to counteract steep exercise-induced increases in MAP 
(86). Previous exercise-induced increases in MCAv mean have been reported, and these 
increases range from 1.5% -20.5%, with accompanying MAP increases between 3%-24% over 
rest in nondemented older adults (8, 85, 86). There are important methodological differences 
between this study and previous studies. First, the present study has 3 to 4.5 times the number of 
older adults than the previous studies (8, 85, 86). Second, compared to the older adults in one 
study (86), our older adults were older by an average of 14 years. Therefore, our work focuses on 
the exercise-induced cerebrovascular response in sexa-, septa-, and octogenarians, while the 
previous work assessed adults in late midlife to early retirement age. Finally, one study only 
assessed older males (85), therefore, limiting the generalizability of the cerebrovascular changes 
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observed in that cohort. Nevertheless, these studies provide a valuable basis on which one can 
design investigations into exercise-induced cerebrovascular functions across the aging spectrum.  
Contrary to our hypotheses, we did not find significant and positive relationships between 
CVRC and TMTBZ or between CVCI percent change and TMTBZ. However, our secondary 
hypothesis found a significant, negative relationship between the CVRC and TMTD, 
corroborating previous work showing cerebrovascular capacity inversely correlates to TMTD 
performance (128). It has been postulated the TMTD may be a better indicator of EF than the 
raw TMTB score because it subtracts the psychomotor and visual component of the TMTA score 
from the TMTB score (137). However, the TMTD is based off the raw TMTA and TMTB 
scores. Therefore, the TMTD score does not take age, sex, or education into consideration, which 
are important demographic factors which influence cognitive reserve and preservation of 
cognitive faculties during aging (138-140).  Hence, our findings suggest greater percent changes 
in perfusion velocity are related to better raw EF scores, but these scores did not account for the 
influence of important cognitive reserve variables. Accordingly, we cannot state a generalization 
that cerebrovascular reserve is related to better EF performance during nondemented aging. 
 
2.5.3. Methodological Considerations of Assessing Executive Function 
 There is an inherent challenge to studying EF due to its component cognitive facets, such 
as working memory, attention, and set-shifting: these components have different operational 
definitions which reflect many task-based tests (141). Unsurprisingly, there is no definitive EF 
test. We chose the TMT as our EF measure because it is widely used, easily administered, and, in 
a comparison of EF tests administered during a functional TCD examination, it elicited the 
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greatest bilateral MCA response (142, 143). However, there is no consensus on which version of 
the TMT is best used for EF assessment, and previous studies have reported using multiple 
iterations of the TMT (143). We chose the TMTBZ as our primary EF measure because it will be 
the primary EF measure used by the National Alzheimer’s Coordinating Center (NACC), which 
coordinates research projects among the nation’s 29 NIH-designated Alzheimer’s Disease 
Centers. We recruited all of our older adults from one of these select national centers. The 
normative calculator which we used to obtain the age, sex, and education-adjusted TMTBZ was 
created to establish reliable cognitive normative data sensitive to demographic characteristics 
among the Alzheimer’s Disease Centers’ research participants. Hence, unlike the raw TMT 
scores and the iterations derived from the raw TMT scores, the strength of TMTBZ is that it 
provides a generalizable measure of EF (119). Further, the normative calculator is designed for 
the Uniform Data Set (UDS), the cognitive battery used by the NACC. There are tests within the 
UDS which probe other aspects of EF, aside from set-shifting, and future investigations could 
capitalize on these tests to further our understanding of EF. For instance calculating z-scores for 
Digit Forward, Digit Forward Length, Digit Backward, and Digit Backward Length tests would 
provide the factor score for attention (119). 
 
2.6. Conclusion 
We investigated a well characterized cohort of nondemented older adults to determine the 
relationships between cerebrovascular function and executive function. Our results suggest that 
MCA velocity has different relationships with executive function performance depending 
whether the cerebrovasculature is at rest or is being challenged. First, higher resting MCAv mean 
relates to poorer executive function performance, but closer inspection of the resting 
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cerebrovascular function and raw executive function scores suggest greater brain blood flow 
velocity and better executive function in our cohort compared to previously studied nondemented 
cohorts. Second, higher exercise-induced CVRC relates to better executive function 
performance, suggesting that greater cerebrovascular reserve correlates to better executive 
function. However, these relationships between MCAv-centered measures and executive 
function were found using raw Trail Making Test scores, but no relationships were found 
between resting and exercise-induced cerebrovascular function and the Trail Making Test score 
normalized for age, sex, and education level. This prevents generalizing the results to other 
nondemented, elderly populations. Further characterization of the relationships between 
exercise-induced cerebrovascular function and executive function may lead to a vascular marker 











 White matter lesion (WML) burden is a marker of brain health and cognitive aging. 
Diminished cerebrovascular function has been implicated in the development of WML burden, 
but the evidence relating resting and dynamic cerebrovascular function to WML burden is 
inconclusive. Hemodynamic measures of cerebrovascular function, specifically middle cerebral 
artery velocity (MCAv) - centered measures, may be useful in elucidating the relationships 
cerebrovascular function and WML burden. Therefore, we set out to elucidate the relationships 
between resting and exercise-induced cerebrovascular function and WML burden in 43 
nondemented adults over age 65 using beat-to-beat transcranial Doppler (TCD) ultrasound at rest 
and during moderate intensity exercise on a recumbent stepper. We obtained the resting and 
exercised-induced cerebrovascular functions, specifically resting MCAv mean, resting 
cerebrovascular conductance index (CVCI), the exercise-induced cerebrovascular reserve 
capacity (CVRC), and the exercise-induced CVCI percent change. We hypothesized that WML 
burden, quantified as lesion volume and lesion count, would negatively relate to resting and 
exercise-induced cerebrovascular functions.  Cross-sectional analysis showed a) no significant 
relationships between WML burden and resting cerebrovascular function, b) an inverse 
relationship between CVRC and WML count (r = -0.260, p = 0.046), and c) a direct relationship 
between the CVCI percent change decrease and WML count (r = 0.348, p = 0.011). These results 
suggest that increases in WML quantity decreases with increases in MCAv change, and WML 
quantity increases as the CVCI percent decrease diminishes. These results partially support our 
hypothesis that cerebrovascular responsiveness to exercise relates to WML burden, because no 
relationships were found between WML volume and exercise-induced cerebrovascular function. 
Hence, we cannot definitively assert that cerebrovascular responsiveness is related to WML 
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burden. Nonetheless, this is the first report to show exercise-induced cerebrovascular 
responsiveness relates to a measure of WML burden. 
 
3.2. Background   
As the brain ages, it is more likely to have damage to its structural integrity. Aging 
associated damage includes white matter lesions (WML) which appear as hyperintensities in 
MRI scans (43). Up to 90% of adults over age 65 have WMLs (44). Clinically, WMLs are 
associated with cerebrovascular disease, Alzheimer’s disease (AD), dementia, impaired motor 
function and reduced cognitive capacity (44, 45, 48). Impaired cerebrovascular infrastructure is 
implicated in WMLs, as histopathology studies provide evidence of brain blood barrier leakage 
associated with WML burden in AD and cognitively normal aging (46, 47). WML burden is 
associated with classic cardiovascular risk factors, such as hypertension and elevated plasma 
cholesterol (49). Consequently, WML burden is often used to identify cerebrovascular pathology 
in the elderly (50).  
 
 3.2.1. White Matter Lesion Burden and Brain Hemodynamics  
There has been speculation that elevated cerebrovascular resistance, or diminished 
cerebrovascular conductance, in AD-related regions may interact with WML burden to affect 
brain aging (144). However, a recent meta-analysis suggests that the diminished hemodynamics 
is a consequence, not the cause, of WMLs (145). Thus, the relationship between WML and 
hemodynamics is not fully understood. We propose assessing hemodynamics during an exercise 
challenge as a way to add valuable knowledge regarding WML burden and cerebrovascular 
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health. A major advantage for using TCD lies in its high temporal resolution (142). This affords 
the opportunity to study dynamic cerebrovascular responses to physiological, vasoactive 
stressors, such as gas inhalation and exercise (8, 73, 86, 146, 147).  
The standard TCD assessment is an examination of the middle cerebral artery velocity 
(MCAv) (72, 73, 148). The MCAv can be incorporated with mean arterial blood pressure (MAP) 
into a ratio termed the cerebrovascular conductance index (CVCI, mathematically MCAv 
mean/MAP), which describes the flow-pressure relationship during a vasomotor response (12). 
Claassen posited the CVCI as the hemodynamic measure which best describes the vasomotor 
response (12). The MCAv mean change reflects the cerebrovasculature’s ability to increase 
blood flow in response to vasoactive stimuli, termed the cerebrovascular reserve capacity 
(CVRC)(80). Diminished CVRC has been evidenced in stroke, diabetes, and coronary artery 
disease (149).  
There is lack of understanding how cerebrovascular function and WML burden interact 
with or cause one another (107, 145).  Although lower resting MCAv mean has been linked to 
more WML burden (107) , there is lack of information regarding the relationships between 
resting CVCI and WML burden. Further, injected acetazolamide and gas-induced CVRC has 
been linked to WML burden (150, 151) , but there is no report on the relationships between 
WML burden and exercise-induced cerebrovascular functions such as CVRC or CVCI. Hence 
we seek to address these knowledge gaps in an effort to increase to elucidate the relationships 





 It is plausible that inducing MCAv-centered changes may elucidate the relationships 
between brain hemodynamics and WML burden (82). This would add valuable information 
regarding the development of a cerebrovascular marker which describes both brain 
hemodynamic function and white matter lesion impact. The main goal of this study was to assess 
the relationship between brain structural integrity and cerebrovascular function by assessing 
WML burden and MCAv-centered outcomes at rest and during exercise.  We hypothesized that 
WML burden would inversely relate to our resting and exercise-induced cerebrovascular 




 We used a cross-sectional study design to assess the relationships between brain 
structural integrity and cerebrovascular function. Participants were recruited into the Trial for 
Assessing Cerebrovascular Regulation and Vascular Risk (TrACR) from the University of 
Kansas Alzheimer’s Disease Center (KU ADC) Alzheimer’s Prevention Program (APP) from 
August 2014 to September 2016. Inclusion criteria were age over 65 years, classification as 
cognitively normal/nondemented with a Clinical Dementia Rating of 0, sedentary or underactive 
lifestyle. Exclusion criteria were DSM-IV defined drug or alcohol abuse within the prior 2 years, 
clinically significant depression or anxiety, insulin-dependent diabetes, myocardial infarction or 
symptoms of coronary artery disease within the prior two years, acute decompensated congestive 
heart failure or class IV heart failure, inability to travel to the KUMC Research in Exercise and 
Cardiovascular Health (REACH) laboratory, and inability for researchers to obtain the MCA 
signal from the transcranial window. Individuals who met the inclusion criteria provided written 
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informed consent. KU ADC recruitment personnel approached those individuals who met the 
TrACR inclusion/exclusion criteria for interest in the study.  If the participant was interested, 
then the KU ADC provided a list of potential TrACR participants to the study coordinator for the 
REACH lab member. This study coordinator then contacted potential participants. If a potential 
participant decided to participate in TrACR, a morning appointment was scheduled. Prior to 
participation in study procedures, all participants provided written informed consent. All study 
procedures were approved by the University of Kansas Medical Center Human Subjects 
Committee.  
 Participants made one visit to the REACH laboratory, which lasted for approximately 4 
hours (earliest possible appointment start time was 7:00 am; latest, 9:00 am). Participants were 
asked to refrain from caffeinated beverages the night before and morning of their study visit and 
refrain from strenuous physical activity 24 hours before study visit.   
 
3.3.2. WML Burden Collection and Analysis 
 White matter lesion burden is currently being collected as part of the KU ADC’s APP. 
Neuroimaging was done under the direction of the KU ADC’s neuroimaging core at the KUMC 
Hoglund Brain Imaging Center. Fluid-attenuated inversion recovery (FLAIR) and anatomical 
(MPRAGE) sequences were acquired.  
We used SPM8 (Welcomme Department of Imaging Neuroscience, London, UK) and the 
VBM8 toolbox (Structural Brain Mapping Group, University of Jena, Jena, Germany) for 
anatomical image pre-processing including segmentation of the image into tissue classes, 
including gray matter, white matter, or cerebrospinal fluid using the ‘new segment’ procedure. 
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We then used the Lesion Segment Tool, Version 2.0.13 (152), to automatically calculate white 
matter lesion segmentation and generate total lesion volume maps. Briefly, the LST algorithm 
coregistered FLAIR images to the native space anatomical image. FLAIR intensity distribution 
was calculated for each tissue class, and these distributions were summed to create belief maps. 
Based on pilot work and visual inspection we selected a k threshold = 0.125 as the cutoff point 
on the gray matter belief map. This threshold was independently corroborated in a cohort with 
multiple sclerosis (data not shown). The LST algorithm generates the white matter lesion 
segments and total lesion volume (mL) and count based on the selected k threshold (153). The 
WML volumes (mL) and counts (quantity) were the primary WML burden measures used for 
correlational and regression analysis. 
 
3.3.3. Cerebrovascular Function Assessment and Analysis 
 Set up. Participants were fitted at rest. We used transcranial Doppler (TCD) ultrasound 
and beat-to-beat-finger plethysmography (154) to get measures of cerebrovascular health. Using 
beat-to-beat measures allowed us to capture changes in mean arterial pressure (MAP) and brain 
blood flow velocity with high temporal resolution (66, 86, 155). We used a protocol similar to 
previously published work (86). This protocol captures mean MCAv and MAP for every cardiac 
cycle over an eight-minute rest period and during eight minutes of steady state moderate 
intensity exercise.  A ROBOTC2MD robotic TCD headset (Multigon, White Plains, NY) was 
placed on the head to capture the left MCA signal. For those participants whose left MCA signal 
was unattainable, we measured right MCAv mean. A Finometer Pro finger plethysmography 
system (Finapres Medical Systems, Amsterdam, Netherlands) brachial cuff was placed on the 
left brachial arm, and the finger cuff was placed on the left middle finger at heart level, to record 
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beat-to-beat MAP.  A Tango M2 brachial cuff (SunTech Medical, Inc., Morrisville, NC) was 
placed on the right arm. Finapres values were compared to the Tango automated blood pressure 
cuff  before the onset of testing (120). If the difference between Finapres and Tango values were 
greater than 15 mm Hg, the Finapres finger cuff was removed then repositioned, until the 
difference was below 15 mm Hg (121). A Capnocheck 9400 capnograph (Smiths Medical, St. 
Paul, MN) and cannula was used to measure breath-by-breath end-tidal CO2  (ETCO2); and a 5-
lead electrocardiogram (EKG) (CardioCard, Nasiff Associates, Central Square, NY) was used to 
collect heart rate.   
 
3.3.4. Resting and Exercise Recordings. Resting and exercise cerebrovascular measures were 
collected while participants remained in a seated position. After completing set up, the 
participants were instructed to remain seated for up to fifteen minutes, breathe through the nose, 
fix their gaze forward, and refrain from talking and movement.  We then began to record resting 
cerebrovascular measures for 8 minutes. After completing the rest recording, participants 
completed one bout of moderate intensity exercise. Moderate intensity exercise was between 
40%-60% of an individual’s heart rate (HR) reserve (122), and exercise target heart rate (THR) 
range was calculated using the Karvonen equation (156): 
THR = ((age-predicted maximum HR− resting HR) × % Exercise Intensity) + resting HR 
 To get participants to reach the THR, we used an exercise protocol that has been adapted 
for use on the NuStep (86). Participants were instructed to use only their legs. As participants 
pedaled at a cadence of 90-100 steps per minute, the resistance was increased until the THR was 
reached and maintained for one minute. Beat-to-beat values were recorded for eight minutes 
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during exercise. Upon completion of eight minutes of exercise, participants cooled down for one 
minute against the lowest resistance (15 watts).  
 
3.3.5. Data Collection and Computations 
Analog signals were delivered through an analog to digital signal converter (NI USB-
6212, National Instruments Corporation, Austin TX), collected and displayed in real time with a 
custom MATLAB program (The MathWorks, Inc., Natick, MA).  We collected an R-wave 
trigger signal, MCAV and MAP at 500 Hz.  The Finapress and TCD beat-to-beat averages were 
aligned with the R-wave signal. We used a custom MATLAB program (R. Maletsky, Lawrence, 
KS) to generate data values.  Beat-to-beat Finapres and TCD values were calculated via 
integration of each cardiac cycle and then dividing the integral by length of the cardiac cycle. A 
custom MATLAB post-processing program computed our primary outcome variables, (ETCO2, 
MAP, MCAv mean and CVCI (mathematically, MCAv mean/MAP).Percent changes in the 
primary cerebrovascular measures were calculated to provide exercise-induced measures. 
Percent change was calculated using the formula: 
Percent Change X = (|(X at moderate intensity exercise – X at rest)|/X at rest) X 100 
where X denotes a primary cerebrovascular measure. Percent change was calculated for ETCO2, 
MAP, MCAv mean (CVRC), and CVCI. 
 
3.3.7. Statistical Analyses 
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 For our first step in testing our hypotheses, we assessed homogeneity of variance and 
normality using Levene’s test for equality of variance and the Shapiro-Wilk test, respectively. 
Non-parametric Spearman correlation was used for data that violated normality or homogeneity 
of variance. One-tailed Pearson correlation was used to assess the relationship between two 
normally distributed variables. One-tailed, non-parametric Spearman correlation (124) was used 
for data that violated normality or homogeneity of variance.  For cerebrovascular measures, we 
conducted paired sampled T-tests to assess differences between rest and moderate intensity 
exercise. When assumptions of normality and homogeneity were not met, we used log-
transformation. For all analyses, α < 0.05 was used as the criterion for statistical significance. All 
analyses were completed with Statistical Package for the Social Sciences software (SPSS, 
version 23, IBM Corporation, Armonk, NY).  
 
3.4. Results 
 We recruited 64 older adults from the Alzheimer’s Prevention Program into TrACR. We 
successfully insonated the MCA and obtained the MCAv signal in 51 participants (79.7%). We 
were unable to use data from an additional 8 participants due to unattainable Finpares and 
capnograph signal. Specifically, one participant did not have a useable Finapres signal both at 
rest and during exercise; one participant did not have a useable capnograph signal at both rest 
and during exercise; two participants did not have a useable capnograph signal during exercise; 
two participants only completed resting recordings; and two participants had completed 
cerebrovascular measures but did not complete MRI. Of the 43 analyzed participants, 28 were 
female. These participants were 71.2 + 5.1 years old, had a body mass index of 26.5 + 4.6 kg/m2, 
and had 17.0 + 2.7 years of education. 
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 Shapiro-Wilk tests were used to determine normality. Resting MCAv mean (p = 0.216), 
and resting CVCI (p = 0.135) were normally distributed. The exercise-induced CVCI percent 
change (p = 0.055) was normally distributed, but the exercise-induced CVRC was not (p = 
0.001). Neither WML burden measure was normally distributed: WML volume (p < 0.001), 
WML count (p = 0.009) Log-transformation of WML burden yielded normal distributions for 
WML volume (logWML volume, p = 0.194, Figure 1) and WML count (logWML count, p = 
0.230, Figure 2). Log transformation of CVRC yielded a normal distribution (logCVRC, p = 
0.031). Hence, the log-transformations allowed us to conduct sets of Pearson correlations.  
 
Figure 1: Normal Distribution of Log-transformed WML Volume (n = 43). Visual depiction 
of non-normal distribution of logWML volume after removal of 1 outlier: A) Right-skewed 
histogram of lowWML volume frequencies; B) Normal Q-Q plot of observed logWML volume 
vs expected normal value; C) and Detrended Normal Q-Q plot of observed logWML volume 




Figure 2: Normal Distribution of Log-transformed WML Count (n = 43). Visual depiction 
of normal distribution of logWML count. A) Right-skewed histogram of lowWML count 
frequencies; B) Normal Q-Q plot of observed logWML count vs expected normal value; C) and 
Detrended Normal Q-Q plot of observed logWML count value vs deviation from normal. 
 
 
3.4.1. WML Burden Relationships with Resting and Exercise-induced Cerebrovascular Function 
  All participants had WMLs. Mean WML volume was 3.3 + 2.8 mL (range 0.20-17.4 
mL) and the mean WML count was 31.4 + 16.9 lesions (range 7-72 lesions). Table 1 shows 
significant differences between the cerebrovascular measures at rest versus during moderate 
intensity exercise. There was a significant exercise-induced MCAv increase, or CVRC (p < 





Measure Resting (+ SD)  Exercise (+ SD) Percent Difference (+ SD) 
ETCO2, mm Hg 33.3 + 5.4 37.4 + 5.3 16.5 + 16.0  
MAP, mm Hg 74.4 + 12.5 104.8 + 23.1 41.5 + 23.0  
MCAv mean, cm*s-1 48.1 + 9.0  54.0 + 12.3 16.8 + 10.6 
CVCI, cm*s-1 *mm Hg-1 0.664 + 0.17 0.521 + 0.15 21.6 + 16.6 
Table 1. Resting and Moderate Intensity Exercise Cerebrovascular Measures (n = 43). 
Exercise-induced differences over rest in capnography, MAP, and measures of cerebrovascular 
function. The values presented are absolute percent changes. ETCO2 = end-tidal carbon dioxide; 
MAP = mean arterial pressure; MCAv = middle cerebral artery velocity; CVCI = 
cerebrovascular conductance index. 
 
 Table 2 shows the relationships between cerebrovascular function and WML burden. No 
significant relationships were found between WML burden and resting cerebrovascular 
measures. 
Cerebrovascular Function logWML Volume logWML Count 
Resting MCAv r = 0.058, p = 0.355 r = 0.023, p = 0.442 
Resting CVCI r = 0.185, p = 0.118 r = 0.078, p = 0.309 
log CVRC r= 0.081, p = 0.303 r = -0.260, p = 0.046* 
CVCI Percent Change r = 0.073, p = 0.322 r =  0.348, p = 0.011* 
Table 2. Relationships between White Matter Lesion Burden and Resting and Exercise-
induced Cerebrovascular Function (n = 43). logWML = log white matter lesion; MCAv = 
middle cerebral artery velocity; logCVRC = log cerebrovascular reserve capacity; CVCI = 
cerebrovascular conductance index. 
 
 Two significant relationships were found between WML burden and exercise-induced 
cerebrovascular function. First. There was a significant, inverse relationship between CVRC and 
WML count (r = -0.260, p = 0.046, Figure 3). Second, there was a significant, direct relationship 
between logWML count and negative CVCI percent change (Pearson r = 0.348, p = 0.011, 
Figure 4). Hence, we found an inverse relationship between WML count and the CVRC, 
suggesting that increases in WML quantity decreases with increases in MCAv change. Further, 
we found a direct relationship between WML count and the CVCI percent change. The CVCI 
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decreased from rest to exercise; therefore, this finding suggests WML quantity increases as the 




Figure 3: Relationship between WML Count and CVRC (n = 43). A significant, inverse 





Figure 4: Relationship between WML Count and CVCI Percent Change (n = 43). A 
significant positive relationship between logWML count and CVCI percent change (r = 0.348, p 
= 0.011).  
 
3.5. Discussion 
 We investigated relationships between measures of WML burden and resting and 
exercise-induced cerebrovascular function in an attempt to further our understanding of the 
brain’s hemodynamic relationship to brain aging. Although there were no significant 
relationships between WML burden and resting cerebrovascular function, we report two main 
findings between WML count and exercise-induced cerebrovascular function, which suggests 
greater WML count relates to lower cerebrovascular responsiveness. Hence, these results 
partially support our hypothesis that cerebrovascular responsiveness to exercise relates to WML 
burden. We are the first to report relationships between WML burden, specifically the quantity of 
WMLs, and exercise-induced cerebrovascular function in a cohort of nondemented, older adults. 
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However, because there were no significant relationships between WML volume and exercise-
induced cerebrovascular function, we cannot make a strong assertion that cerebrovascular 
responsiveness is related to WML burden.  
 
3.5.1. WML Burden and Resting Cerebrovascular Function 
A recent review and meta-analysis by Shi and colleagues suggests lower brain blood flow 
is related to more WML burden across various clinical and non-clinical populations using 
various techniques, including TCD (145). For instance, a positron emission tomography study 
showed older adults with asymptomatic WMLs had reduced perfusion in white matter and the 
basal ganglia compared to control subjects, suggesting a link between hypoperfusion and brain 
structural damage in a nonclinical population (157). Tzourio and colleagues assessed bilateral 
MCAv mean in 628 elderly subjects to show a link between resting cerebrovascular function and 
WML severity. Further, a regression analyses done by Tzourio and colleagues showed subjects 
with the lowest MCAv mean were more than 4 times more likely to develop severe WML burden 
and more than twice as likely to develop moderate WML burden compared to subjects with the 
highest MCAv mean (107). 
Contrary to our hypotheses, there were positive, non-significant relationships between 
our resting measures of cerebrovascular function and measures of WML burden. Hence, we did 
not reproduce prior work which detected inverse relationships between WML burden and resting 
brain blood flow using neuroimaing or between WML and brain blood flow velocity using TCD 
(107, 150, 157). Prior studies investigating the link cerebrovascular function and WML burden 
did not quantify WML burden by volume or quantity; instead the WML burden was classified by 
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severity using graded scales. Further, in a majority of these studies, clinical populations were 
studied, and the symptomatic manifestations of WMLs were linked to the clinical conditions 
(158-161). In contrast, we studied a non-clinical, relatively healthy cohort of nondemented older 
adults. Hence, the lack of a relationship between resting cerebrovascular measures and WML 
burden may be a result of studying the cerebrovasculature of a healthy cohort without comparing 
this cohort to a clinical group. This idea is further supported by the WML volume of our cohort. 
Specifically, our cohort had lower than average WML volume compared to other studies using 
the Lesion Segmentation Toolbox software (131, 132). For instance, in one study of 
nondemented older adults over 55 years, the average WML volume among the four subject 
groups ranged from 13.6 mL to 25.8 mL (131). In another study of adults aged 32-85 and free of 
neurological disease, the average WML volume was 37.9 mL, and the range was between 3 to 99 
mL. Thus, it is plausible that our cohort of older adults may have been, on average, spared by 
the age-related accumulation of WML volume. One possible explanation may be the incidence of 
hypertension and use of blood pressure medications in our cohort. Hypertension is known to be a 
factor in the link between hypoperfusion and WML burden (161). Forty-three percent (19/43) of 
these older adults were on blood pressure medications, which could have possibly tempered the 
development of WML volume in this cohort. A second explanation may be education. In one 
study, there was relationship between more severe WMLs and poorer cognitive performance in 
older adults with lower levels of education (11 years and under), yet no relationships were seen 
between WML and cognition in adults with higher levels of education (162). Thus, higher 
education levels may protect against cognitive decline and brain damage. Our cohort had, on 
average 17 years of education and were cognitively normal, so it is possible these older adults’ 




3.5.2. WML Burden and Exercise-induced Cerebrovascular Function 
To our knowledge, this is the first report showing relationships between WML burden 
and exercise-induced cerebrovascular function. However, because these relationships were 
formed between exercise-induced cerebrovascular function and one of two WML burden 
measures, our data partially supports our hypotheses. Nonetheless, we recapitulated the 
relationship between cerebrovascular reserve and brain structural integrity (150, 163). 
Cerebrovascular reserve reflects the cerebral arterioles compensatory ability to affect perfusion 
changes in response to a physiological stressor, such as exercise or carbon dioxide exposure (80, 
149). Prior studies have shown an inverse link between WML burden and CVRC (150, 151), but 
no study has reported on possible links between exercise-induced cerebrovascular function and 
WML burden. Neuroimaging studies posit the possibility that perfusion is compromised within 
the WMLs. For instance, one study of 21 nondemented 85-year olds reported a 47% CVRC 
within the grey matter, a 52% CVRC within normal-appearing white matter, and 30% CVRC 
within WMLs (150). Hence, perfusion was compromised within the WMLs compared to normal-
appearing white matter and grey matter. Further, a recent MRI study showed that the normal 
white matter which eventually become WMLs have prolonged vascular response times and lower 
CVRC compared to normal white matter which did not become WMLs (151). Thus, it is likely 
that areas with WMLs have cerebrovasculature that has been subjugated to damage associated 
with a combination of ischemia, atherosclerosis, hypertension, or hypoperfusion (150, 151, 164).   
We demonstrate that the CVCI percent change can be a cerebrovascular reserve marker. 
The CVCI describes the flow-pressure relationship within the cerebrovasculature (103), and may 
best capture the vasomotor response to physiological stress (12). The CVCI decreased between 
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rest and exercise; therefore, the 22% change between rest and exercise in CVCI reflects the 
magnitude of this decrease, and this decrease was directly related to WML count. Previous 
research has shown exercise-induced CVCI changes coinciding with CVRC values between 
1.5% - 21% and MAP percent changes between 3%-24% in older adults (84-86). Fisher and 
colleagues showed an absolute CVCI percent decrease of 16.4% in older adults completing 
moderate exercise on a cycle ergometer (86). This drive in CVCI percent change was due to the 
24% increase in MAP over rest, suggesting that the body maintains brain blood flow velocity in 
response to physiological stress by increasing arterial pressure (86). However, their cohort only 
had a 1 cm/s MCAv mean increase over rest, which was a 1.6% CVRC. In juxtaposition, our 
cohort had a 17% CVRC, a 21% CVCI decrease, and a 42% MAP increase from rest. Hence, 
compared to Fisher et al, our cohort had a much larger CVRC and lower CVCI percent change 
driven by a larger MAP change. This could be explained by the age discrepancy between the two 
studies, as our cohort was on average 14 years older than Fisher et al older adult cohort. 
Regardless, in both elderly cohorts, the exercise-induced CVRC is more conservative than the 
MAP change. This mathematically explains why the CVCI decreased during exercise, suggesting 
that vasoconstriction occurs to counteract exercise-induced increases in MAP.  
Comprehensive understanding of exercise-induced cerebrovascular markers requires 
further characterization of the MCAv increases and the flow-pressure relationship across the 
spectrum of aging. Accomplishing this could provide further knowledge of which exercise 
workloads produce comparable cerebrovascular effects across different age groups. For instance, 
Ogoh and colleagues conducted a cycling study that did report CVCI numbers (146). They 
compared the effect of cycling intensity on MCAv-centered measures in a sample of seven 
young adults. Participants cycled at mild (target heart rate of 90 beats per minute), moderate (120 
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beats per minute), and heavy (150 beats per minute) workloads for eight minutes each. 
Compared to rest, the CVRC at mild, moderate, and heavy intensities were 5%, 11.4%, and 
16.4%, respectively. The respective MAP changes were 1.1%, 8.0%, and 20.4%. The respective 
CVCI percent changes were 5.8%, 4.3%, and -2.8% (146). Hence, only heavy exercise induces a 
negative CVCI percent change in young adults. However, this change was not as large as the 
CVCI decrease we report in older adults. We report a 22% decrease in CVCI as result of 
exercise, and this decrease is accompanied by a 42% increase in MAP. In Ogoh and colleagues’ 
work, the exercise-induced 3% decrease in CVCI is accompanied by a 20% increase in MAP. 
Therefore, when older adults face vascular stress, there is a more drastic drive to increase MAP 
in order to maintain the cerebral flow-pressure relationship (85, 86).  This MAP increase may 
partially explain why WML burden increases with age. Elevated blood pressure is linked to 
WML in normal older adults (164). The bioavailability of nitric oxide declines with age and 
sedentary behavior, and this compromises endothelial function during aging, ultimately 
contributing to vascular stiffening and hypertension (165, 166). The older adults in our cohort 
were sedentary, and 14 of the 43 (32%) of these adults had a pre-exercise blood pressure above 
normotensive. Hence, we cannot remove the possibility of increased vascular stiffening and/or 
altered endothelial function in a substantial proportion of our cohort. Therefore, our reported 
relationships between exercise-induced cerebrovascular functions and WML count may be more 
indicative of vascular aging mechanisms than brain structural atrophy. 
Our data shows a link between exercise-induced cerebrovascular function and WML 
burden quantity in a nondemented elderly cohort. Most research has focused on cerebrovascular 
function at rest, during gas inhalation/rebreathing, or during sit-to-stand (12, 92, 167), but there 
is a lack of information regarding exercise-induced cerebrovascular functions. In this small 
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sample, we present data suggesting that exercise-induced CVRC and CVCI percent changer are 
cerebrovascular functions linking cerebrovascular responsiveness and brain structural integrity. 
Hence, future work should determine if exercise-induced cerebrovascular functions can be used 
as long-term markers of the vasomotor-brain structural integrity relationship during normal 
aging. For example, recapitulating this relationship throughout the course of an exercise 
intervention would add further evidence of exercise’s capacity to preserve cerebrovascular 
function (168), with preservation of brain structural integrity being linked to cerebrovascular 
preservation. 
 
3.5.3. Methodological Considerations  
 The cross-sectional design limits our interpretation and generalizability of our results. We 
aimed to study nondemented older adults, but our use of MCAv-centered outcomes as 
biomarkers only provides a snapshot of the relationships between brain hemodynamics and brain 
structural integrity. Further, participants only completed one exercise session, so we cannot draw 
conclusions as to what effect repeated exercise sessions would have on the relationship between 
brain hemodynamics and WML burden. Therefore, the use of MCAv-centered outcomes as long-
term markers of these relationships needs to be established in larger studies across multiple time 
points in a variety of clinical conditions including, but not limited to mild cognitive impairment, 
Alzheimer’s disease, vascular dementia, and stroke. Additionally, future work is needed to 
determine if an exercise-intervention affects these relationships in larger samples across the 
spectrum of healthy and pathological brain aging. This could set the foundation for using 
exercise-induced cerebrovascular markers as indicators of cerebrovascular and structural decline, 
preservation, or improvement.  Recent work by Spencer showed that MCAv-centered responses 
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to a hypercapnic challenge remain stable over 6 months in adults over age 55, and their pending 
work will assess the effects of a six month exercise intervention on MCAv-centered outcomes 
(42). Therefore, future work could potentially supplement Spencer’s work and could help 




A cross-section of nondemented older adults completed one exercise session so that we 
could determine the relationships between cerebrovascular function and WML burden. Through 
assessment of middle cerebral artery velocity-centered measures at rest and during exercise, we 
showed that exercise-induced percent changes in cerebrovascular function, particularly the 
cerebrovascular conductance index and cerebrovascular reserve capacity, relate to WML burden 
count, but not WML volume. Thus, we only have partial support of our hypotheses, mitigating 
the potential use of exercise-induced cerebrovascular measures as markers of brain structural 
integrity. Future work is needed to determine if these relationships can be reproduced along the 
spectrum of brain aging, including adults under 65 years, across multiple time points, and in a 
larger cohort, which would determine the utility of using these cerebrovascular measures as long-
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4.1. Abstract  
It has become increasingly clear that cerebrovascular dysfunction is an important driver 
of cognitive decline. Mounting evidence suggest that accumulation of Alzheimer’s disease 
pathology, beta-amyloid, interferes with and may be worsened by cerebrovascular dysfunction. 
However, little is known about how beta-amyloid accumulation directly impacts cerebrovascular 
regulation when homeostasis of the system is challenged. We report on the cerebrovascular 
regulation of older individuals with normal cognition. We characterized beta-amyloid with 
florbetapir PET scans. Brain blood flow velocity of each participant was measured at rest and 
during moderate intensity exercise, allowing us to calculate a reserve capacity. Cognitive testing 
was also performed at a separate visit. We found that greater beta-amyloid load was associated 
with worse cerebrovascular reserve capacity (CVRC; b=-9.3, p=0.03). Beta-amyloid loads but 
not CVRC were related to aspects of cognition. These the results extend the growing literate in 
humans that cerebrovascular dysregulation and beta-amyloid accumulation are closely linked. 
CVRC may be an important early marker of AD pathology. 
 
4.2. Introduction 
Continuous regulation of brain blood flow is essential at rest, during daily activity and 
physical demand (exercise) for optimal brain health (83, 169-176). A healthy cerebrovascular 
system maintains constant global brain blood flow across multiple conditions despite changes in 
metabolic demands, carbon dioxide production and perfusion pressure changes (177). Age-
related decline in cerebrovascular regulation may be associated with decreased oxygen delivery 
and suboptimal removal of metabolic by-products that lead to white matter hyperintensities and 
eventually impaired cognitive function (16, 178). 
76 
 
There is evidence in animal models that the presence of beta-amyloid, a hallmark 
pathology of Alzheimer’s disease (179), may interfere with endothelial-dependent response of 
the cerebral arteries and impair cerebrovascular autoregulation (180, 181). Specifically, one 
study reported transgenic mice that expressed higher levels of beta-amyloid showed the greatest 
disruption in cerebrovascular autoregulation across various ranges of blood pressure (180). If 
impaired cerebrovascular function is one mechanism by which beta-amyloid accumulation 
causes neurodegeneration (115), replication in humans would have profound implications 
regarding brain health especially during daily activities and exercise. 
Exercise challenges the body to respond to an increase in metabolic demand. Therefore, 
blood flow and oxygen delivery must match the brain’s metabolic needs despite changes in blood 
pressure and carbon dioxide (CO2) levels (83). In this study, we present a novel experimental 
protocol for assessing cerebrovascular regulation in cognitively normal individuals with and 
without elevated beta-amyloid. We employed a moderate intensity exercise protocol to assess 
cerebrovascular reserve capacity (CVRC) in the middle cerebral artery. We hypothesized that 
greater amyloid loads would be associated with lower CVRC. Using established criteria for 
amyloid load (SUVR), we then divided the participants into 2 groups (elevated, non-elevated) to 
examine whether group differences were present for CVRC. We also sought to explore the 
relationship of CVRC, amyloid burden and cognition, hypothesizing that CVRC would mediate 








Individuals were recruited from the University of Kansas Alzheimer’s Disease Center’s 
(KU ADC) Alzheimer’s Prevention Program. To be included in the study, individuals were: 1) 
65-90 years of age, 2) classified as cognitively normal/nondemented with a Clinical Dementia 
Rating = 0, 3) sedentary or underactive lifestyle, and 4) completion of Amyvid PET scan within 
6 months of our experimental procedures. Exclusion criteria were: 1) DSM-IV defined drug or 
alcohol abuse within the prior 2 years, 2) clinically significant depression or anxiety, 3) insulin-
dependent diabetes, 4) myocardial infarction or symptoms of coronary artery disease within the 
prior two years, 5) acute decompensated congestive heart failure or class IV heart failure, 6) 
major orthopedic disability, 7) inability to exercise due to pain or restrictions from physician. All 
individuals provided written informed consent.  The KU institutional review board provided 
approval for all study procedures.  
Before coming to our laboratory at KU Medical Center, participants refrained from 
caffeinated beverages for 12 hours, physical activity for 24 hours and no large meal within 2 
hours of the procedures (2). Procedures began in the morning for all participants. After consent, 
each individual was classified as having low, moderate or high cardiovascular risk according the 
American College of Sports Medicine (182). The laboratory room for the experimental session 
was dimly lit, quiet and temperature maintained between 22-24 degrees Celsius (183, 184). 
External stimuli were kept to a minimum during the testing session.  
The left middle cerebral artery was used for the TCD ultrasound with a 2-MHz probe 
(RobotoC2MD, Multigon) placed over the temporal window and fixed in place using a robotic 
TCD headpiece. If the left MCA was not obtainable, then the right side was used. Once the 
optimal signal was identified, we began the imaging process for mean MCA velocity 
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(MCAVmean). Individuals performing the TCD data collection were blinded to the beta-amyloid 
status (elevated, non-elevated). 
A finger plethysomograph (Finometer Pro) was placed on the middle finger of the left 
hand supported at the level of the heart on an adjustable padded bedside table. The finger 
plethysomograph collected continuous measures for mean arterial pressure (MAP). It has been 
reported that MAP values measured at the finger are typically lower than intrabrachial pressure 
at rest (185) and during exercise (186). End-tidal CO2 (ETCO2) was assessed using a nasal 
cannula and capnograph (BCI Capnocheck 9004, Smiths Medical St. Paul, MN). We used a 5-
lead electrocardiogram (ECG) for heart rate (HR). The 8-minute average MAP, ETCO2 and 
MCAVmean for each condition (resting and moderate intensity) were used. 
 
4.3.1. Resting Protocol. Once signal acquisition occurred and was stable for the ECG, Finometer 
Pro, TCD and ETCO2, participants sat quietly on the recumbent stepper (NuStep, T5XR) to rest 
for 15 minutes. During the last 8 minutes of rest, baseline data for all variables was recorded.   
 
4.3.2. Exercise Protocol. After the 8-minute resting data collection, the participant performed a 
single bout of exercise at moderate intensity using the recumbent stepper (187). Moderate 
intensity exercise was defined as 40% - 60% of age-predicted heart rate (HR) reserve (187). 
Participants maintained a step rate of 90 steps per minute (188). All participants began at 40 
watts while the resistance was increased until the targeted HR range was reached. Data collection 
commenced when a steady state HR was maintained for one minute. The participant exercised at 




4.3.3. Vascular Measures. MCAvmean, MAP and ETCO2 were resampled to 10Hz. We calculated 
cerebrovascular reserve capacity (CVRC) as the change in MCAvmean (cm/s) from rest to 
moderate intensity exercise. We reported mean MCAvmean, MAP and ETCO2 at rest and baseline.  
 
4.3.4. Dementia and Cognition. All participants were well-characterized as having normal 
function and cognition during a clinical consensus conference based on a Clinical Dementia 
Rating (189) and neuropsychological test battery. The neuropsychological test battery is common 
to all National Institute on Aging-designated Alzheimer’s Disease Centers, the Uniform Data Set 
(119). We created cognitive composite scores of these domains by averaging unadjusted 
standardized scores in each domain: executive function, attention, language, and processing 
speed (119). Memory tests in the Uniform Data Set (UDS) were changed during our study by the 
National Alzheimer’s Coordinating Center. Consequently, we did not have consistent UDS 
memory tests for all participants. Therefore, we used the Free and Cued Selective Reminding 
Test as a measure of memory (190). We standardized the total number of items recalled without 
cue to a similar, previously characterized sample (191). 
 
4.3.5. Brain Imaging. To assess beta-amyloid, participants were administered intravenous 
florbetapir F-18 (370 MBq). Florbetapir PET images were obtained on a GE Discovery ST-16 
PET/CT scanner. Two five-minute duration PET brain frames were acquired continuously, 
approximately 50 minutes after florbetapir administration. Frames were then summed and 
attenuation corrected.  
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Three trained raters (192) considered both visual and quantitative information on each 
scan. Quantitative analysis was performed using MIMneuro software (MIM Software Inc, 
Cleveland, OH), normalizing the PET image to a template and standardizing florbetapir uptake 
to the whole cerebellum, creating a standardized uptake value ratio (SUVR). Final determination 
of scan status, elevated vs. non-elevated, was the majority determination of the 3 raters. We 
calculated the mean of the anterior cingulate, posterior cingulate, precuneus, inferior medial 
frontal, lateral temporal, and superior parietal cortex as the global beta-amyloid burden. 
  
4.3.6. Analyses. All statistical analyses were performed using R (version 3.2.4 (193)). We 
performed linear regression to explore relationships between our vascular, cognitive and brain 
amyloid measures. Between group differences (amyloid-elevated, non-elevated) were assessed 
using Welch’s two-sample tests (due to different sample sizes and variance characteristics) or 
chi-square tests as appropriate. We set α=0.05 to protect against Type I error and did not correct 
for multiple comparisons due to the exploratory nature of this study.  
 
4.4. Results 
We consented 73 individuals into our experimental protocol. Of those consented, we 
were unable to acquire a quality signal at baseline and during moderate intensity exercise on 17 
individuals. These individuals were not different in age, sex or cardiovascular risk factor 
classification from those individuals we were able to acquire a signal on. Signal failure was due 
to: 1) unable to insonate the MCA (n = 16), 2) significant artifact during exercise (n =1). 
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 Of the remaining 56 individuals (see Table 1; 14 elevated, 42 non-elevated), the groups 
were similar in age, sex and cardiovascular risk (p>0.1). Individuals with elevated amyloid 
performed notably worse in the memory (F=8.99, p=0.006) and processing speed (F=10.2, 









Age, years 70.0 [4.7] 72.9 [5.6] 70.7 [5.0] 
Female 28 [66.7%] 9 [64.3%] 41 [66.1%] 
Cardiovascular 
Risk, n 
 18 Moderate  
 24 High 
  3 Moderate  
11 High 




-0.14 [0.81] -0.34 [0.64] -0.19 [0.77] 
Memory  
z-score 
0.78 [1.01] -0.11 [0.93] 0.56 [1.06]* 
Language 
z-score 








0.41 [0.61] -0.11 [0.49] 0.28 [0.62]* 
Table 1. Baseline demographics and cognitive performance scores. Values are mean 
[standard deviation] unless otherwise noted. *p<0.01 
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Because blood flow is sensitive to CO2 (ETCO2) and blood pressure (MAP) we first 
checked for group differences in these measures (Table 2). Neither baseline ETCO2 (F=0.003, 
p=0.95) nor moderate intensity exercise ETCO2 (F=1.08, p=0.44) were different between groups. 
Baseline MAP was different at rest (F=4.5, p=0.04) with the non-elevated individuals having a 










6.9 [5.5] 4.4 [3.7] 6.2 [5.2]† 
Mean Middle Cerebral 
Artery Velocity at Rest 
(cm/s) 
48.5 [8.8] 45.6 [10.5] 47.8 [9.3] 
Mean Middle Cerebral 
Artery Velocity during 
Mod. Exercise 
(cm/s) 
55.4 [11.1] 50.0 [11.1] 54.1 [11.2] 
Mean Arterial Pressure at 
Rest (mmHg) 
74.8 [13.4] 67.7 [9.9] 73.1 [12.9]* 
Mean Arterial Pressure 
during Mod. Exercise 
(mmHg) 
105.0 [24.0] 95.3 [17.3] 102.6 [22.7] 
Mean End-tidal CO2 at 
Rest (mmHg) 
33.1 [5.9] 33.1 [4.4] 33.1 [5.6] 
Mean End-tidal CO2 
during Mod. Exercise 
(mmHg) 
37.5 [4.9] 38.4 [3.2] 37.5 [4.9] 
Table 2. Rest and Exercise Measures for CVRC, MAP and ETCO2. All measures mean 
[standard deviation]. *p=0.04; †p=0.06 
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4.4.1. Vascular Measures. Our primary measure of cerebrovascular health was cerebrovascular 
reserve capacity (CVRC), the change in MCAvmean (80) between resting and moderate intensity 
exercise. We assessed the direct relationship of CVRC and amyloid burden. Lower CVRC was 
significantly associated with greater global amyloid burden (b=--9.3, p=0.03; Figure 1). That is, 
each increase in SUVR of 0.1 units was associated with a 0.9 cm/s decline in CVRC ([95% 
confidence interval [-17.6 -0.89]). This relationship held even when controlling for age and 
blood pressure (b=-10.4, p=0.02). We did find that CVRC was 36% lower for individuals with 
elevated amyloid compared to those who were non-elevated but was not significant (F=3.69, 
p=0.06).  





4.4.2 Cognitive Measures. We then assessed the relationship of CVRC to our cognitive 
measures with linear regression of each cognitive factor on CVRC. Higher CVRC trended 
toward an association with better processing speed (b=0.03, p=0.06). This relationship was 
somewhat attenuated when controlled for age and blood pressure (b=0.02, p=0.11). No other 
cognitive domains were associated with CVRC. In contrast, greater global amyloid burden was 
associated with worse processing speed (b=-1.32, p=0.01), and memory (b=-2.31, p=0.008) and 
better language performance (b=1.26, p=0.044).  
Given our findings we performed simple mediation analysis to see if CVRC was 
responsible for any part of the relationship of beta-amyloid and processing speed. In our sample, 
CVRC did not mediate the relationship of beta-amyloid and processing speed. 
 
4.5. Discussion  
The brain does not tolerate large increases in oxygen demand and blood flow delivery 
during exercise (194). However, the brain increases blood flow in response to the neuromuscular 
activation requirements of hand-grip exercise (195) and physical exercise (83, 169-176). 
Exercise-induced brain blood flow response is less understood in older adults who may be at risk 
for brain pathology. By conducting the present study, we aimed to understand whether the 
presence of beta-amyloid influences CVRC. Our primary finding was that lower CVRC was 
significantly associated with greater global amyloid burden in cognitively normal older adults.   
Previous work in an animal model reported that mice (2-3 months old) with a genetic 
disposition for higher levels of amyloid precursor protein (APP) demonstrated disruption in 
cerebral autoregulation in response to pressure changes whereas wild-type showed no disruption 
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(180). Further, the APP+ mice with higher levels of beta-amyloid showed the greatest disruption 
in cerebrovascular regulation. Although this present study did not assess cerebrovascular 
autoregulation, we did examine changes in CVRC with concomitant changes in MAP from rest 
to moderate intensity exercise.  Our findings in cognitively normal older adults demonstrate that 
lower CVRC was observed in those with higher levels of global beta-amyloid and are consistent 
with beta-amyloid-driven changes in cerebrovascular control seen in mice. 
We divided the individuals into those considered beta-amyloid elevated and non-elevated 
to examine the CVRC response. Those in the elevated amyloid group (n = 14) exhibited a 36% 
lower CVRC response than those considered non-elevated amyloid (n = 42). We acknowledge 
that the non-elevated amyloid group had a significantly higher resting MAP but we report no 
differences between the groups for changes in MAP or ETCO2 in response to exercise. Indeed, 
we would have expected to see greater CVRC of the elevated group as they increased their 
exercise MAP more over baseline than the non-elevated group. There may be other 
cardiovascular measures that could influence CVRC that we did not examine such as cardiac 
stroke volume, carotid-intima thickness, or arterial stiffness. We did capture cardiac risk and 
report similar representation across the 2 groups for moderate and high cardiovascular risk. 
Future work should include a comprehensive cardiac and vascular profile to extend upon this 
initial work. These findings suggest that greater level of global beta-amyloid may affect CVRC 
and have critical implications for cerebrovascular health in older adults.  
A published review of the literature focused on cerebrovascular reserve and the potential 
implications of impaired cerebrovascular function in the progression to vascular dementia and 
Alzheimer’s disease (168). In our study, we found that CVRC trended toward an association with 
better processing speed (p=0.06) but no other cognitive domains were associated with CVRC. 
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These results are encouraging since our older adults were considered cognitively normal. 
Individuals in the earliest stages of cognitive change, Mild Cognitive Impairment, may be a 
particularly interesting cohort to test for cerebrovascular associations with cognition. This would 
allow future work to determine whether CVRC could function as a surrogate marker of brain 
health or risk for converting to frank dementia.  
 The present study has several limitations. First, this study in humans did not focus on the 
mechanisms that may influence CVRC in those with elevated global amyloid.  There may be 
other factors that influence cerebrovascular function such as cardiac function, hypertension and 
peripheral vascular dysfunction. Second, we did not use controlled methods for regulating 
changes in blood pressure or CO2 when measuring MCAv mean across all subjects. Rather, we 
assessed each individual during moderate intensity exercise, which is influenced by individual 
responsiveness. However, we believe our methodology is a strength of the study as it presents 
more real-world challenges versus CO2 gas inhalation. Finally, we did not account for individual 
APOE genotype. APOE is linked to higher risk of dementias and cerebrovascular diseases, and 
can therefore influence brain aging (196, 197). Thus, future investigations could determine how 
APOE impacts cerebrovascular responsiveness. 
 
4.6. Conclusion 
The findings of the present study demonstrate that lower CVRC in response to moderate 
intensity exercise is related to higher global amyloid burden. These results corroborate prior 
animal data whereby the cerebrovascular effects of beta-amyloid may have a role in the 










 Cerebrovascular function describes the interface of heart and brain functions. This body 
of work addresses important gaps regarding the role of cerebrovascular function in the aging 
brain. Cerebrovascular function is of tremendous interest to numerous fields, including, but not 
limited to, gerontology, physical therapy, rehabilitation medicine, psychology, neurology, and 
neurosurgery. The original aims of this work were to elucidate the links between resting 
cerebrovascular function and executive function; cerebrovascular function and brain structural 
integrity; and cerebrovascular function and a hallmark marker of Alzheimer’s pathology, β-
amyloid. However, secondary analyses of exercise-induced cerebrovascular functions revealed 
novel data which incrementally advances our understanding of cerebrovascular responsiveness 
and the links between cerebrovascular responsiveness, executive function, brain structural 
integrity, and β-amyloid. Hence, the findings are a prelude to further investigation into 
cerebrovascular responsiveness and its links to brain aging. Development of markers of 
cerebrovascular responsiveness may add supplemental information regarding brain aging. Long-
term development of such markers may provide us with surrogate markers of brain pathological 
risk, i.e., a non-invasive marker of dementia risk. This could then serve as the basis for 
implementing brain-sparing interventions, particularly exercise interventions in high-risk 
populations, such as pre-clinical Alzheimer’s individuals. Hence, the sum of this work lays the 
foundation for assessing whether longitudinal exercise-induced cerebrovascular functions could 





5.1.1. Chapter 2: The partial relationships between cerebrovascular function at rest and 
during exercise in nondemented aging 
 The purpose of this initial experimental chapter was to establish a link between 
cerebrovascular function and one facet of cognition, executive function (EF). Both 
cerebrovascular function and EF decrease with age. Hence, we set out to establish correlations 
between greater cerebrovascular function, particularly hemodynamic measures, and better EF 
performance in a cohort of sedentary, nondemented older adults. To this end we obtained the 
following resting and exercise-induced cerebrovascular functions while participants were seated 
on a recumbent stepper:  the resting mean middle cerebral artery velocity (MCAv mean); the 
resting cerebrovascular conductance index (CVCI); the exercise-induced percent change in 
MCAv mean, known as cerebrovascular reserve capacity (CVRC); and the exercise induced 
change in CVCI (CVCI percent change). We administered Trail Making Test Parts A and B 
(TMTA, TMTB) and calculated three iteration scores: age, sex, and education-normalized TMT 
B z-score (TMTB-Z); the delta, or difference, score between TMTA and TMTB (TMTD); and 
the ratio score of TMTB:TMTA (TMTR).  
 First, our results showed a direct relationship between resting MCAv mean and TMTR, 
contrary to our hypothesis, and thus indicates that greater resting brain blood flow velocity 
directly relates to poorer EF performance. However, further inspection of the cohort revealed 
that a) the MCAv mean was higher than normal compared to values previously reported in older 
adults; b) the cohort had smaller average white matter lesion burden compared to reported values 
in the literature, indicating less age-associated brain damage; and c) the cohort had better TMT 
performance compared to previously reported values in older adults. Thus, the cohort may have 
had relatively greater brain blood flow velocity and better EF performance compared to other 
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elderly cohorts. Second, we found a negative relationship between CVRC and TMTD. This 
supported our hypothesis and suggests greater cerebrovascular responsiveness is related to 
greater EF performance.  
We report partial support for our hypotheses with these two findings as relationships 
were not found between all cerebrovascular measures and TMT iterations. Further, no 
relationships were found between resting and exercise-induced cerebrovascular functions and the 
TMTBZ, preventing us from generalizing the results to other nondemented, elderly populations. 
Nonetheless, this chapter lays the ground for further characterization of the relationships between 
cerebrovascular responsiveness and executive function. Ultimately, this may lead to a 
cerebrovascular marker sensitive to age-related executive decline, and this marker may be 
employed in identifying executive dysfunction during aging. 
 
5.1.2. Chapter 3: Assessing white matter lesion burden relationships with cerebrovascular 
function in nondemented aging 
White matter lesion (WML) burden is used as a marker for brain aging. There is 
contradictory evidence regarding the causative role of cerebrovascular dysfunction in WML 
burden development (145). Hence, the relationship between WML burden and cerebrovascular 
function is inconclusive. The purpose of the second experimental chapter was to assess 
relationships between resting and exercise-induced cerebrovascular function and WML burden 
using the same cohort of nondemented adults studied in Chapter 2. We calculated WML volume 
and WML count (quantity), and we conducted correlational analyses between these measures 
and the four cerebrovascular functions assessed in Chapter 2:  MCAv mean, CVCI, CVRC, and 
91 
 
CVCI percent change. We expected WML burden to inversely relate to resting and exercise-
induced cerebrovascular functions. 
 Our results did not demonstrate a relationship between WML burden and resting 
cerebrovascular function. Further, we did not find any relationships between WML volume and 
exercise-induced cerebrovascular function. However, we did find two relationships between 
WML count and exercise-induced cerebrovascular function. First, there was an inverse 
correlation between CVRC and WML count. Second, there was a direct correlation between the 
CVCI percent change decrease and WML count. This is the first report showing direct links 
between exercise-induced cerebrovascular function and WML burden in a cohort of healthy, 
older adults.  Our results indicate that cerebrovascular responsiveness to exercise relates to WML 
burden quantity, thereby showing partial support for our hypotheses. The results are promising 
because this cohort had relatively lower than average WML burden and better than average 
cerebrovascular function. Thus, it is plausible this negative relationship would be greater in 
magnitude in clinical cohorts such as adults with mild cognitive impairment or dementia. 
Therefore, through further development, the CVRC and CVCI percent change could be used as 
markers of structural brain damage during the course of both healthy and pathological brain 
aging.  
 
5.1.3. Chapter 4: Cerebrovascular reserve capacity is blunted during exercise in people with 
elevated β-amyloid 
 There is evidence suggesting that cerebrovascular function interacts with the β-amyloid, a 
protein hallmark of Alzheimer’s disease pathology. However, little is known about how cerebral 
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β-amyloid levels affect cerebrovascular responsiveness. Therefore, in the third experimental 
chapter, we assessed exercised-induced cerebrovascular function in 56 nondemented older adults 
with and without elevated β-amyloid levels. We studied the MCAv at rest and during moderate 
intensity exercise, which allowed us to capture the cerebrovascular reserve capacity (CVRC). 
First, we expected that greater β-amyloid loads would associate with lower CVRC. Second, 
using the standard uptake value ratio (SUVR), a previously established criteria for quantifying β-
amyloid load, we divided the older adults into 2 groups (elevated and non-elevated) to examine 
whether CVRC differed between groups. Lastly, we set out to explore the relationship of CVRC, 
β-amyloid burden, and cognition. We hypothesized that CVRC would mediate any relationship 
between β-amyloid burden and cognition in this cohort of older adults. 
Our results showed that greater β-amyloid load was associated with worse CVRC, 
supporting our initial hypothesis. Second, there was a trend that the CVRC was lower in adults 
with elevated β-amyloid compared to those without elevated levels. Third, we found a trend 
between higher CVRC and faster processing speed, but this trend was dampened when the 
analysis was controlled for age and blood pressure. Fourth, we found that greater β-amyloid 
levels significantly related to slower processing speed, worse memory performance, and better 
language performance. Finally, contrary to our hypothesis, the CVRC did not mediate any 
relationships between β-amyloid and cognition. Thus we show that cerebrovascular 
responsiveness is related to β-amyloid. Therefore, further work could establish cerebrovascular 







5.2.1. Sample characteristics 
By collaborating with the University of Kansas Alzheimer’s Disease Center (KU ADC) 
we took advantage of the opportunity to study cerebrovascular function in a well-characterized 
cohort of non-demented older adults. These older adults were free of vascular disease, diabetes, 
orthopedic disability, and substance abuse. Although these adults were sedentary, they did not 
any have physician restriction against performing exercise. Hence, all the experimental chapters 
add to the literature regarding exercise responses in nondemented, sedentary older adults (198). 
Additionally, in Chapter 4, we further characterized the participants into one of two groups based 
on the level of an Alzheimer’s pathological marker, β-amyloid. This effectively separated 
participants into a “preclinical” Alzheimer’s group versus a lower Alzheimer’s risk group. Thus, 
we were able to assess the impact of hallmark Alzheimer’s pathology on cerebrovascular 
responsiveness, and we found a trend towards cerebrovascular responsiveness being lower in 
preclinical Alzheimer’s (199). Hence, it is plausible that assessing older adults with mild 
cognitive impairment, vascular dementia, or dementia would reveal significantly diminished 
exercise-induced cerebrovascular responsiveness similar to the diminished CVRC seen using 
non-exercise stimuli (149, 200, 201). 
  
5.2.3. Exercise Challenge 
 The exercise-induced increases in cerebrovascular function have been previously 
documented (8, 86, 146), but little is known regarding the extent exercise increases 
cerebrovascular function in older adults do to the relatively small samples of older adults studied. 
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Additionally, little is known regarding the cerebrovasculature response to exercise in individuals 
who have higher risk for brain pathology, such as individuals with preclinical AD. 
Cerebrovascular regulation is an intricate, integrative process that is driven by carbon dioxide, 
mean arterial pressure (MAP), neurovascular coupling, and autonomic nervous system 
functioning (33). All of these factors are profoundly changed by exercise challenge (83). Thus, 
employing the cerebrovascular response to an exercise challenge provides investigators the 
opportunity to study cerebrovascular responsiveness, at a higher temporal resolution than 
neuroimaging, and without the contraindications associated with neuroimaging and gas exposure 
(33, 61).  A review by Querido & Sheel suggests that the exercise-induced increases in 
cerebrovascular function, measured via TCD, are dependent on intensity (83). We had the older 
adults perform one session of moderate intensity exercise on a recumbent stepper. Our results are 
in line with previous reports of exercise-induced CVRC values between 15-20% in nondemented 
older adults (84, 85). We are the first to show exercise-induced cerebrovascular responsiveness 
on a recumbent stepper related to executive function, brain structural integrity, and a β-amyloid.  
These links were found in a cohort of nondemented older adults; therefore, this work lays the 
foundation for future investigations to assess these relationships in not just nondemented older 
adults, but also older adults with stroke, mild cognitive impairment, and other dementias. 
 
5.2.4. Cerebrovascular Function and Executive Function 
 Executive function (EF) is an umbrella term which encompasses various cognitive skills, 
such as task switching, planning, inhibition, working memory, sustained attention, and selective 
attention (97). Executive function is a major concern during aging because decreased EF is 
linked to decreased functional status in retired adults (202), and in some adults, executive 
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dysfunction precedes memory deficits prior to the diagnosis of AD (203). There is evidence of 
lesions in the frontal cortex, particularly in the frontal-striatal tracts underlying executive 
function, developing alongside medial temporal atrophy in areas underlying memory (102). 
Hence, capturing the early decline of executive function is important in identifying the time 
window of burgeoning memory impairment in adults who will first develop non-amnestic mild 
cognitive impairment, which could develop into dementia. However, there is no consensus 
regarding the biomarker which best captures the nascent executive dysfunction preceding the 
development of dementia.  
 At the advent of this project, our discussion focused on the use of cerebrovascular 
markers as biomarkers for EF. Decreased brain hemodynamics has been implicated in the 
development of executive dysfunction (92, 117). For example, Bailey and colleagues showed 
that adults with chronic traumatic brain injury had impaired cerebrovascular function, 
specifically a reduced CVRC after exposure to hypercapnic gas (92), and these individuals had 
diminished performance across the Trail Making Tests, which are widely-used measures of EF 
(143). Specifically, there was a 38% slower completion time in the TMTA and a 43% slower 
completion time in the TMTB, compared to controls (92). 
 In Chapter 2, we reported on the links between TMT performance and resting and 
exercise-induced cerebrovascular function. Originally, we proposed to use one iteration of the 
TMTB, specifically a z-score normalized for age, sex, and gender. The purpose of this was two-
fold. First, we aimed to generalize the results with regards to older adults, but raw TMT scores 
vary from study to study and between education levels (133, 143). Hence, accounting for the 
influence of age, sex, and education affords the opportunity to generalize EF performance (119). 
Second, and related to the first justification, we recruited all the participants from one of the 
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NIH-designated Alzheimer’s Disease Centers. The normative calculator was designed for use by 
these centers and for other studies utilizing any aspect of the Uniform Data Set (UDS) cognitive 
battery, which includes the TMT. The UDS designates the TMTBZ as the measure of EF.  
Therefore, by using the TMTBZ, we aimed to contribute data to a larger normative data set 
sensitive to demographic characteristics among the centers’ participants. However, our TMTBZ 
results did not support our hypotheses, which thus limits the generalizability of the significant 
relationships we found between cerebrovascular function and EF.  
The significant relationships we found were based on raw TMT data. Hence, we have 
partial evidence that the Trail Making Test is related to resting and exercise-induced 
cerebrovascular function, and the relationships between cerebrovascular function and EF is 
conditional upon the cerebrovasculature being at rest or being stressed via exercise. When at rest, 
greater cerebrovascular function relates to poorer EF performance, but greater exercise-induced 
cerebrovascular function relates to better EF performance. It is possible we did not find 
significant relationships between all cerebrovascular functions and all TMT scores due to greater 
resting brain blood flow velocity, better executive function/ higher raw TMT scores, and 
potential limited impact of white matter lesions observed in our cohort compared to previous 
reports. Nonetheless, by showing relationships between cerebrovascular function and EF in a 
cohort of relatively healthy older adults, we argue that cerebrovascular function markers may be 






5.2.5. Cerebrovascular Function and Brain Structural Integrity  
  In Chapter 3, we sought to elucidate the relationships between resting and exercise-
induced cerebrovascular function and WML burden. The importance of this work is rooted in the 
lack of understanding how cerebrovascular function and WML burden interact with or cause one 
another (107, 145). Hence, by studying the relationship between exercise-induced 
cerebrovascular function and WML burden, we hoped to further our understanding by using 
exercise-induced measures of cerebrovascular responsiveness as new and potential markers of 
WML burden. We failed to reproduce prior work which showed inverse relationships between 
WML burden and resting cerebrovascular function (107, 150, 157). We suspect this is due to our 
cohort having lower than average WML volume compared to previous research using the Lesion 
Segmentation Toolbox software in older adults (131, 132). Further, factoring in the WML 
volume standard deviation would still indicate our cohort had smaller than average WML 
volume. Furthermore, our cohort had greater resting MCAv compared to previously published 
data (8, 204). Factoring the general health of the cohort (no vascular disease; control of 
hypertension with medication), it is reasonable to conclude the greater than average resting 
MCAv is indicative of healthier than average cerebrovascular aging. Having less WML burden 
and greater resting cerebrovascular function could preclude finding significant relationships, as 
the correlations would be based on a narrow distribution of both factors. Thus, our significant 
findings pertaining to exercise-induced cerebrovascular function and WML count is promising 
because we essentially show a link between more WML burden and worse cerebrovascular 
responsiveness in healthy older adults. Thus, future investigations can determine whether 




5.2.6. Cerebrovascular Function and Amyloid Burden 
The Amyloid Cascade Hypothesis (205) posits that increases in β-amyloid deposition is 
the crucial pathophysiological step leading to amyloid plaque creation, tau neurofibrillary tangle 
formation, neuronal death, and ultimately, dementia. This hypothesis has been the focal point of 
AD research for over 25 years (206), yet the failure of recent anti-β-amyloid drug trials (207, 
208) suggests our understanding of the role of β-amyloid in brain aging is still unclear. Although 
individuals with elevated levels of β-amyloid are classified as having preclinical AD (199), 
elevated levels of β-amyloid does not necessarily precede the development of AD. For instance, 
post-mortem brain studies of cognitively-healthy older adults showed substantial levels of β- 
amyloid (209) and PET studies revealed up to 30% of cognitively normal older adults have 
substantial levels of β- amyloid (210, 211). However, β-amyloid does place individuals at higher 
risk for AD (212), and increased levels of cerebral β-amyloid in older adults are linked to 
decreased cognition (213). The purported role of the blood brain barrier in β-amyloid clearance 
(214), the binding of hemoglobin to β-amyloid (215),  the role of β-amyloid in fibrinogen 
oligomerization (216), and the mediation of endothelial function (217, 218) by β-amyloid in 
animal models suggest an interaction between β-amyloid and vascular function. However, the 
human literature concerning this interaction is not fully understood, and little is known about 
how β-amyloid load directly impacts cerebrovascular function. Thus in Chapter 4, we sought to 
characterize the relationship between β-amyloid load and cerebrovascular responsiveness. 
 We leveraged the KU Alzheimer’s Disease Center’s (KU ADC) Florbetapir β-amyloid 
imaging. The Florbetapir tracer selectively binds to cerebral amyloid, thus allowing us to further 
characterize older adults into a non-elevated or elevated/preclinical AD group. At this 
dissertation’s outset, we had originally proposed to study 17 older adults with elevated β-
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amyloid compared to non-elevated controls matched for age (+ 3 years), sex, and cardiovascular 
risk factors. The KU ADC had projected to annually screen and recruit 400 older adults, 100 of 
whom were expected to display elevated levels of β-amyloid. However, the recruitment efforts 
did not meet these projections. In two-and-half years, we have recruited 14 individuals with 
elevated amyloid. Thus, Chapter 4 presents the evolution of our original aim. Instead of studying 
17 matched pairs, we looked at 56 older adults, and 14 had elevated amyloid levels.  Our results 
suggest greater β-amyloid load relates with worse cerebrovascular responsiveness. Further, a 
trend showing lower CVRC in adults with elevated β-amyloid and a trend showing higher CVRC 
linked to faster processing speed provide further basis for investigating the impact of amyloid 
load on cognitive performance and cerebrovascular function.  
 
5.3. Limitations 
 This body of work is not without limitations. First, most of our analyses looked at 
relationships between cerebrovascular measures and other indicators of brain aging. Hence, we 
cannot deduce possible causative mechanisms. Second, we used a cross-sectional design, which 
also prevents us from inferring mechanisms of causation. Nonetheless, the underlying theme of 
our aims was to establish relationships between resting and exercise-induced cerebrovascular 
function and not to establish causative relationships. By demonstrating relationships between 
cerebrovascular function and other indicators of brain aging, we set the rationale for longitudinal 
investigations, which could theoretically determine causative relationships. Third, we did not 
capture a wide range of brain aging. Our cohort was primarily made of adults in their mid-60s 
and early 70s, and only 9% of our cohort was over age 80. Hence, we captured a limited 
spectrum of nondemented aging. Further, brain hemodynamics begin to decline in the third 
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decade of life (30), so determination of cerebrovascular function being a long-term determinant 
of diminished brain aging requires investigations which look at cerebrovascular function decades 
before retirement age.  Therefore, to adequately use cerebrovascular responsiveness as a marker 
of aging, we would need to recapitulate our findings in cohorts younger and older than our 
cohort.  
 
5.4. Future Directions 
5.3.1. Develop Exercise-induced Indices as Markers of Cerebrovascular Function  
 This work lays the foundation for using cerebrovascular responsiveness as markers of 
brain aging. Further use of exercise-induced cerebrovascular markers could provide additional 
knowledge regarding the aging brain. For instance, use of pulsatility index (PI) and resistive 
index (RI) percent changes could show how downstream vascular resistance is impacted by 
exercise (160, 219). The PI is calculated as the difference between peak systolic and diastolic 
velocities over the mean blood flow velocity, and the resistive index (RI) is the difference 
between peak systolic and diastolic velocity over the peak systolic velocity (219). Because 
downstream cerebrovascular resistance is normally low in order to maintain brain blood flow 
(219), knowing how exercise impacts these indices may help distinguish between healthy and 
pathological brain aging.  
 
5.3.2. Characterize Executive Function in Relation to Cerebrovascular Responsiveness 
 As previously mentioned, we used a single, widely-used test to measure executive 
function, the Trail Making Test. However, it does not capture all facets of executive function, 
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such as attention. Within the Uniform Data Set, the attention factor score can be calculated using 
Digit Forward, Digit Forward Length, Digit Backward, and Digit Backward length scores (119). 
The Stroop task assesses inhibition, an executive function profoundly affected by frontal lobe 
damage (220). The KU ADC collects the Digits test and Stroop task performance. Thus, future 
cross-sectional and longitudinal investigations could employ the Trail Making Test, the Digit 
tests, and the Stroop task to capture more comprehensive details of executive function than this 
body of work. 
 
5.3.3. Characterize Regional White Matter Lesion Burden and Cerebrovascular Responsiveness 
 Although we are the first to report relationships between exercise-induced 
cerebrovascular function and WML quantity, we cannot draw inferences as to where these 
WMLs occur. Specifically, periventricular and deep white matter lesions may influence 
cognitive decline differently in nondemented and demented aging (44). Thus, future 
investigations could determine if cerebrovascular responsiveness mediates the relationship 
between WML burden and cognitive aging.  
 
5.4. Clinical Implications 
 This body of work has potential clinical implications regarding cerebrovascular health 
and brain aging markers. Particularly, stroke and dementias are conditions in which 
compromised cerebrovascular function are implicated in the decline of cognitive function (221-
223). Studying exercise-induced cerebrovascular reserve could be of use to physical activity or 
exercise regimens aimed at staving off age-related cognitive and neural declines. Specifically, 
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the methodology we present here affords the ability to look at real-time cerebrovascular 
responses to exercise, and the MCAv-centered measures could be used as biomarkers of 
cognitive aging through further development. Thus, the cerebrovascular functions presented in 
this work could be used to assess how cerebrovascular responsiveness mediates the relationship 
between cognition and fitness (168, 224), giving investigators, and potentially, clinicians, 
cerebrovascular “targets” for which interventions could work through in order to ultimately 
preserve brain and cognitive function. For instance, further development of the exercise-induced 
CVRC may lead to its use as a non-invasive marker of dementia risk in adults physically able to 
perform exercise. Exercise interventions could then be aimed at high-risk populations, such as 
pre-clinical Alzheimer’s individuals, and could be designed to enhance or preserve CVRC, in 
efforts to preserve brain and cognitive function. Hence, the sum of this work lays the foundation 
for using exercise-induced cerebrovascular functions as potential non-invasive indicators of brain 
aging.   
 
5.5. Conclusion 
 In conclusion, the totality of this work addressed important gaps regarding 
cerebrovascular responsiveness in aging, and it laid the foundation for further development of 
exercise-induced cerebrovascular function. Such development could have implications in stroke 
and dementia research and treatment, impacting the rehabilitation, cognitive, and neurological 
fields. This work advances our understanding of cerebrovascular responsiveness and its links to 
executive function, brain structural integrity, and β-amyloid.  Long-term development of the 
markers may provide us with surrogate markers of pathological brain aging. The findings are a 
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prelude to further investigation into cerebrovascular responsiveness and its links to and possible 
roles in the development of both healthy and pathological brain aging.  
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 The dynamic response to a stimulus such as exercise can reveal valuable insights into 
systems control in health and disease that is not evident from the steady-state perturbation.  
However, the dynamic response profile and kinetics of cerebrovascular function have not been 
determined to date. We tested the hypotheses that bilateral middle cerebral artery blood flow 
mean velocity (MCAV) increases exponentially following the onset of moderate intensity 
exercise in ten healthy young subjects. The MCAV response profiles were well fit to a delay (TD) 
+ exponential (time constant, τ) model with substantial agreement for baseline (L: 69, R: 64 
cm·s-1, coefficient of variation, c.v. 11%), response amplitude (L: 16, R: 13 cm·s-1, c.v. 23%), 
TD (L: 54, R: 52 s, c.v. 9%), τ (L: 30, R: 30 s, c.v. 22%), and mean response time (MRT) (L: 83, 
R: 82 s, c.v. 8%) between left and right MCAV as supported by the high correlations (e.g., MRT 
r=0.82, P<0.05) and low c.v.’s. Test retest reliability was high with coefficient of variations for 
the baseline, amplitude, and MRT of 3, 14, and 12%, respectively. These responses contrasted 
markedly with that of three healthy older subjects in whom the MCAV baseline and exercise 
response amplitude were far lower and the kinetics slowed.  A single older stroke patient showed 
baseline ipsilateral MCAV that was lower still and devoid of any exercise response whatsoever. 
We conclude that kinetics analysis of MCAV during exercise has significant potential to unveil 
novel aspects of cerebrovascular function in health and disease. 
 
New & Noteworthy 
 Resolution of the dynamic stimulus-response profile provides greater understanding of 
underlying physiological control processes than steady-state measurements alone. We report a 
novel method of measuring cerebrovascular blood velocity (MCAv) kinetics under ecologically 
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valid conditions from rest to moderate intensity exercise. This technique reveals that brain blood 
flow increases exponentially following the onset of exercise with: 1. a strong bilateral coherence 
in young healthy individuals, and 2. reveals potential for unique age and disease specific profiles.  
 
Introduction 
 Vascular control across different organs subserves a range of primary requirements from 
thermoregulation in the skin to blood filtration in the kidney and support of cellular energetics in 
the heart, skeletal muscle and brain. In each organ blood flow control must be regulated in 
accordance with the required function within an error tolerance presumably dictated by the 
extent of damage incurred to the organ or organism by hypoperfusion. The brain does not endure 
the up-to-100 fold increases in oxygen demand (V̇O2) incurred by vigorously contracting 
muscle(s). However, it supports extremely high oxidative function at rest and this increases in 
response to the neuromuscular activation requirements of physical exercise (83, 169-176).   
 
 Unlike skeletal muscle the brain is notably lacking in energy storage mechanisms (21, 
225, 226) and increases its fractional oxygen extraction to ~50% rather than the 80-90% found in 
skeletal muscle (176, 227). Thus, once thought to be constant (228), there is now substantial 
evidence that cerebrovascular blood flow increases during exercise (83, 169-173, 175, 176, 229-
231). Moreover that increase is highest, and laterally symmetrical, for cycling at moderate 
exercise intensities but reduced for vigorous and maximal intensities where hyperventilation and 
hypocapnia induce cerebral arteriolar vasoconstriction (83, 170, 174-176, 232, 233). Given the 
brain’s lack of O2 stores, and intolerance to anoxia, that elevated blood flow and oxygen delivery 




 Whereas quantitative steady state responses of blood flow, ventilation or V̇O2 can provide 
valuable information, resolution of the response kinetics to a change in demand from rest to 
exercise, for example, can uncover sentinel features of the underlying control mechanisms. Such 
analyses are technically and mathematically challenging but also extremely rewarding. For 
instance, kinetics analyses of pulmonary and muscle V̇O2 have demonstrated that, in health but 
not disease (e.g., heart failure, Type II diabetes, COPD), the speed of the kinetics response at 
exercise onset is limited by mitochondrial function and not O2 delivery (227, 234, 235). At the 
arteriolar level kinetics analyses of vasodilation (and vasoconstriction) have extended these 
findings and explain how O2 delivery temporally and quantitatively matches oxidative demands 
in healthy young but not aged muscles (236-239).  Similar analyses for ventilation have unveiled 
how the carotid body facilitates ventilatory dynamics and blood-gas and acid-base regulation 
across metabolic transitions (240). It is surprising therefore that cerebrovascular kinetics have 
not been studied to date.  
 
 The exercise hyperemia of the brain has been demonstrated with anterior and middle 
cerebral artery blood velocity (MCAV) (169, 171-173, 175), and “steady-state” cerebral blood 
flow increasing by 10-30% following the onset of low and moderate-intensity exercise (171, 241, 
242). It is also thought that life-long physical activity results in greater cerebral blood flow to 
support brain tissue, possibly through angiogenesis and improved cerebrovascular 
responsiveness to demand (243, 244). In this regard cerebral endothelial nitric oxide synthase 
levels are increased following an exercise training program in rodents (245, 246) supporting that 
chronic exercise elevates cerebrovascular control as seen for the coronary and skeletal muscle 
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vasculatures (247). It is not known whether such training improves either the speed or amplitude 
of the hyperemic response of brain blood flow in response to physical exercise or alternatively 
whether that response is altered or compromised by age and or diseases such as Alzheimer’s, 
stroke, diabetes or heart failure, in part, because kinetics analyses of cerebrovascular blood flow 
have not been conducted. 
 
 The MCA was chosen as the vessel of interest for assessing the kinetics of 
cerebrovascular regulation since previous work has focused on the MCA during exercise (171, 
241-243, 248, 249). Here we report the use of a novel analysis method for assessing the kinetics 
of cerebrovascular regulation to provide the first characterization of the dynamic cerebrovascular 
(specifically the middle cerebral artery blood mean velocity, mean MCAV, (termed MCAv 
throughout) response to exercise. Specifically, we tested the hypotheses that: 1) following the 
onset of exercise MCAV increases exponentially, 2) the parameters of this response (amplitude, 
time constant, mean response time) are not systematically different between right and left MCA, 
and 3) the kinetics profile and kinetics parameters may be substantially altered by age and 
disease (stroke). Specifically, we demonstrate the putative application of this technique for 
characterizing differences across age and disease states with the future purpose of identifying 
and testing therapeutic strategies for better preserving, or recovering, cerebrovascular and, 
potentially, brain function.  
 
Materials and Methods 
 Ten healthy young adults with low cardiac risk (250) and three older adults without 
cardiovascular disease but considered high cardiac risk, in part, because of their age (250) were 
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recruited to participate in the study. One additional individual, 88 days post-ischemic stroke, was 
recruited as a case example of known cerebrovascular injury. No individuals were considered to be 
competitive athletes (Table 1 contains participant demographics). KU Medical Center Human 
Subjects Committee approved all experimental procedures, which complied with the Declaration of 
Helsinki. Institutionally approved written informed consent was obtained from each individual prior 
to participation in the study.  We did not directly assess hormone level but pre-menopausal females 
exercised around the early follicular phase of the menstrual cycle (241, 251). Female participants 
over 65 were considered post-menopausal.  
 
 Participants were screened either over the phone or in person.  Inclusion criteria were: 1) 20-
85 years of age, 2) ability to perform repeated bouts of moderate intensity exercise, and 3) 
transportation to KU Medical Center for testing. Exclusion criteria were: 1) inability of study staff to 
acquire signal of the MCA using transcranial Doppler ultrasound, 2) inability to perform the 
alternating leg movements on the seated recumbent stepper (T5XR NuStep, Inc. Ann Arbor, MI), 3) 
diagnosis of Parkinson’s disease, mild cognitive impairment, Alzheimer’s disease or multiple 
sclerosis, and 4) pulmonary disease or dependency on supplemental oxygen. Before reporting to the 
laboratory at KU Medical Center, participants were asked to abstain from the following prior to 
testing:  food for two hours prior to testing (241), caffeine for at least six hours, and vigorous exercise 
for twelve hours. The laboratory room for the experimental session was dimly lit, quiet and 





 After written informed consent was obtained, resting heart rate (HR) was taken by a hand-held 
device (Tuffsat Ohmeda, GE Healthcare, Chicago, IL).  Then the participant was familiarized with 
the equipment and procedures. All participants were instructed to breathe only through their nose 
during the experiments. A nasal cannula was placed in the participants’ nares and if needed, 
adjustments to the position of the nasal cannula were made to ensure optimal end-tidal carbon dioxide 
(PETCO2 in mmHg) reading (BCI Capnocheck Sleep 9004 Smiths Medical, Dublin, OH).  The nasal 
cannula remained in place at rest and during exercise familiarization to allow the individual to 
practice breathing through their nose. During testing, participants were observed closely to ensure 
breathing was exclusively through their nose. 
 
 Participants practiced the reciprocal motion of the recumbent stepper at the prescribed rate of 
120 steps per min. The recumbent stepper was used for this study since it is the modality of choice for 
older adults (252) and is often used with those after stroke due to motor and balance impairments 
(188, 253-255). Next, a target work rate was identified by setting the resistance to 40 watts and then 
increasing at a rate of 10 watts every 30 s until their target heart rate for moderate intensity exercise 
was achieved and maintained for one min.  Moderate intensity exercise was defined as 45-55% of HR 
reserve calculated using the Karvonen formula and age predicted maximum heart rate (APMHR) of 
220-age (250). Work rates estimated to be in the upper region of the moderate intensity domain were 
specifically selected because we wished to evoke the greatest increase in MCAV (83, 170, 174-176, 
232, 233).  The lactic acidosis and consequent hyperventilation associated with vigorous and maximal 
intensity exercise were avoided because hypocapnia induces cerebral vasoconstriction and reduced 
cerebral blood flow (233). After the target work rate was found, study staff then completed ACSM 
cardiac risk stratification (250), non-exercise V̇O2max estimate questionnaire (256), participant 
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demographics and information pertaining to past medical history and physical activity participation  
(~20 min) allowing the HR returned to within 5 beats of resting.   
 
 Three laboratory members conducted the experimental sessions. One individual read 
instructions to the participant using a standardized script, the second team member monitored beat-to-
beat blood pressure (Finometer, Finapres Medical Systems, Amsterdam, The Netherlands) and 
PETCO2 and the third team member set up and monitored the transcranial Doppler ultrasound (TCD) 
(Multigon Industries Inc. Yonkers, NY), electrocardiogram (ECG) (Cardiocard, Nasiff Associates, 
Central Square, NY) and data acquired through an analog to digital data acquisition unit (NI-USB-
6212, National Instruments ) and custom written software operating in MATLAB (v2014a, The 
Mathworks Inc. Natick, MA). 
 
Experimental Protocol 
Set up  
 Participants were seated in the semi-recumbent stepper. Heart rate was monitored 
continuously using V5 on the ECG.  
Blood Pressure. The left arm was placed on a padded table and was adjusted to ensure the arm 
remained at the level of the right atrium (241) and continuously monitored to ensure minimal 
movement during the experiment. Beat-to-beat BP was acquired from the left middle finger using a 
finger photoplethysmograph (Finometer PRO, Finapres Medical Systems, Amsterdam, The 
Netherlands). Right arm brachial artery BP was assessed with the arm at heart level using an 
automated sphygmomanometer with microphone (Tango M2, Suntech, Inc. Morrisville, NC). This 
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allowed for comparison between devices to ensure accurate BP measures prior to data collection 
(241).  
Middle Cerebral Artery Velocity (MCAV).  MCAV was measured using TCD at rest and during 
exercise. Using an adjustable headband, 2MHz probes with ultrasonic gel were placed over the 
cranial temporal bone window (257).  The MCA was accurately identified using practice standards 
for probe positioning and orientation, depth selection and flow direction (257). Depth and gain 
settings were adjusted to ensure optimal signal strength and then the probes were fixed in place.  
 
Experiment 
 During the initial set up, the participants sat quietly for 20 min and were reminded to keep 
their arms and hands relaxed, breathe through their nose and to face forward. The recording period 
started with 90 s of rest. After 60 s of rest, the participant was informed that exercise would begin 
shortly.  At 84 s, a visual countdown was provided for the participant to begin exercise. We chose to 
standardize exercise initiation while minimizing the ramp-up time to target intensity. All subjects 
began exercising at 60% of their target work rate for the subsequent moderate intensity exercise.  We 
increased the watts at 10-s intervals using 1/3 the difference of the starting and target watts until the 
target power was achieved resulting in attainment of the target work rate 30 s into the transition.  
Subjects maintained this work rate for 6 min and then cooled down for 2 min. The participant rested 
quietly until HR reached +/-5 beats of their resting HR before subsequent exercise bouts. Subjects 
completed three rest-to-exercise transitions, which were temporally aligned to the start of exercise 
and then averaged. This procedure improves the signal-to-noise ratio and thus better reveals the 




 Test re-test reliability for the baseline (BL) and criterion kinetics measurements: response 
amplitude (AMP), time delay (TD), time constant (τ) and mean response time (MRT, TD + τ) were 
established for all eight younger participants across the three transitions.   
 
Data Acquisition 
 All variables were sampled at 500 Hz. To analyze, the data were divided by R-to-R cardiac interval. 
For each cardiac cycle, mean finger arterial pressure calculated as area under the pressure curve 
(MAP in mmHg), mean left and right MCAV (cm·s
-1), PETCO2, and HR (beats per min) were 
calculated. Data with R-to-R intervals greater than 5 Hz or changes in peak blood flow velocity 
greater than 10 cm·s-1 in a single cardiac cycle were considered not physiologically real and censored. 
Acquisitions with more than 15% of data points censored were discarded.  MCAV, MAP and PETCO2 
were then interpolated to 0.5 Hz using shape-preserving, piecewise cubic interpolation.  
 
MCAV Model Fitting  
 Kinetics analyses were conducted for the left and right MCA during exercise using 3 s time-binned 
mean values over the entire exercise bout with a mono-exponential model:  
MCAV(t) = BL + Amp(1 – e 
–(t – TD)/τ) 
where MCAV(t) is the MCAV at any point in time, BL is the baseline before the onset of 
exercise, Amp is the peak amplitude of the response, TD is the time delay proceeding the 
increase in MCAV, and τ is the time constant. Mean response time (MRT) was calculated as the 
sum of the model derived τ and TD. The total exercising MCAV response (Tot) was calculated as 
the sum of BL and Amp. Time-to-63% of the steady-state response was assessed as a model-
independent measure of the response. Specifically, this measurement provides a non-biased 
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 All curve fitting and statistical analyses were performed using a commercially available 
software package (SigmaPlot 12.5, Systat Software, San Jose, CA, USA). Differences in resting 
values, exercise responses, and kinetic parameters were analyzed using Student’s paired t-tests. 
Differences between younger and older participants were analyzed using Student’s unpaired t-
tests. Normality was verified via the Shapiro-Wilk normality test. Differences were considered 
significant when p <0.05. The limits of agreement between left and right MCAV variables were 
investigated using the Bland-Altman method (259). Data are presented as mean ± standard error 
unless otherwise noted.  
 
Results 
Young healthy participants 
 Pertinent cardiorespiratory variables. Eight healthy young participants (6 female, 2 
male) were included in the data analysis. Two subjects were excluded from kinetics analysis 
because a valid MCAV signal was not acquired from both the left and right MCA. The work rate 
for the exercise transitions was 104 ± 5 (range: 85 - 125) Watts. Consistent with moderate 
intensity exercise (45-55% of HR reserve) from rest to exercise, HR increased from 86 ± 5 to 
129 ± 6 beats·min-1 (p<0.01) and MAP increased 8 ± 4 mmHg (p=0.08). PETCO2 was increased 




The test retest reliability (n=8) was high with coefficients of variation for the BL, AMP, and 
MRT of 3, 14, and 12%, respectively.  
 
Mid cerebral artery blood velocity (MCAV) 
Overall response profile. MCAV increased from rest to exercise in all young subjects with a 
mean Amp of 15.5 ± 3.1 (range: 9.0 - 35.7) cm·s-1 for the left and 13.4 ± 2.1 (range: 7.4 - 25.6) 
cm·s-1 for the right MCA (p=0.21) (Table 2). As seen from the exemplar presented in Figure 1, 
MCAV increased in a close-to-exponential pattern being well-fit by a delay + exponential 
function. This notion was supported by inspection of each individual response, analysis of the 
residuals (Figure 1, line at bottom of panel) and the high r2 of the fits themselves: left MCAV 
0.85 ± 0.03 (range: 0.73 - 0.97); right MCAV 0.82 ± 0.04 (range: 0.6 - 0.95). In addition, the 
coefficient of variation of the actual time-to-63% of the steady-state response with the MRT 
calculated by the model was a mere 5 and 11%, for the left (82.7 ± 4.1 vs 83.3 ± 5.2 s; p=0.78) 
and right MCA (81.9 ± 6.0 vs 82.1 ± 6.5; p=0.98), respectively, again indicating good model fit 
to the response. The delay was highly variable among subjects being 21.0 - 76.6 s for the left and 
12.1 - 64.1 s for the right MCA (Table 2).  Similarly τ varied from 13.6 - 52.8 s for the left and 
12.8 - 53.8 s for the right MCA. No MCAV parameter (i.e., BL, Amp, MRT, etc.) were 
significantly correlated with work rate or ΔPETCO2 (data not shown).  
 
 Figure 2 presents the best (top) and worst (bottom) model fits from our group of young 





Is there systematic lateral heterogeneity? As evident in Table 2 there was a close correspondence 
of the mean values between the left and right MCA for BL, Amp, TD, τ, or MRT although the 
coefficient of variation did differ among the parameters (i.e., BL 10.8%, Amp 22.8%, τ 22.1%, 
TD 8.7%, MRT 7.6%). Figure 3 demonstrates the close correlation for the overall response 
(MRT, r = 0.82, P<0.05) with this conclusion supported by the Bland-Altman plot (Figure 3, 
bottom panel). In addition when the absolute exercising total MCAV was examined during 
exercise there was no difference between left (84.8 ± 4.8 cm·s-1) and right (77.8 ± 4.7 cm·s-1, 
p=0.07) with a coefficient of variation of 11.1%. 
 
Older adult participants and post-ischemic stroke patient 
 Older adult participants (2 female, 1 male) were considered high cardiovascular risk due 
to reporting existing signs/symptoms of cardiac disease (ankle edema (n=2), orthopnea (n = 1)) 
and the following risk factors: age, sedentary lifestyle, hypertension and dyslipidemia(250). The 
work rate for the exercise transitions was 88 ± 7 (range: 70 - 90) Watts and trended towards 
being significantly lower than younger participants (p=0.06). In stark contrast to the young 
healthy participants, the older adults had a lower MCAV BL in both the left (43.1 ± 5.2 cm·s
-1, 
p=0.002) and right MCA (44.7 ± 7.0 cm·s-1, p=0.03) as well as a markedly slowed MRT for the 
left (117.9 ± 10.3 s, p=0.009) but not the right MCA (99.4 ± 7.1, p=0.17). Despite the lower 
work rate, BL, and slowed kinetics for these three older subjects, the AMP was not reduced 
significantly in either the left (10.4 ± 2.6 cm·s-1, p=0.37) or right MCA (11.8 ± 2.4 cm·s-1, 
p=0.67) compared to the younger participants. An older subject is represented by the open circles 




  The patient had a right ischemic stroke in the MCA territory. A dramatic response for the 
right MCAV was the extremely low BL (37.9 cm·s
-1) and absence of any increase in MCAV with 
exercise (Fig. 4). The signal for the left MCA was not attainable. 
 
Discussion 
 The principal novel findings of the present investigation are aligned closely with our 
hypotheses.  Namely, following the onset of moderate intensity exercise MCAV in young healthy 
individuals increased, after a time delay, in a close-to-exponential profile to achieve an elevated 
steady-state within 2-3 min.  The MCAV values for BL,  the response parameters (Amp, τ, MRT, 
TD and Tot) and exercising steady-state were not systematically different between right and left 
MCA with coefficients of variation between 8 and 23% and high correlation coefficients (up to 
0.82 for MRT).   The three older healthy individuals exhibited lower baseline and total amplitude 
of MCAV response following the onset of exercise and notably slower MCAV kinetics, with τ 
and MRT being well outside the range of their younger healthy counterparts (i.e., 2-4 standard 
deviations longer than the young average, Table 2). In marked contrast to the healthy individuals 
the stroke patient exhibited a baseline that was markedly lower than the healthy young or aged 
subjects and displayed absolutely no increase in MCAV during exercise. 
Given the current emphasis on cerebrovascular health in brain aging and disease, understanding 
the speed of these kinetics responses may have important clinical implications. There is 
mounting evidence that vascular disease, poor cerebral endothelial function and cardiac risk 
factors (hypertension, hyperlipidemia) contribute to vascular dementia and Alzheimer’s disease 
(19, 260-265). We may find that resolution of the kinetics response to a change in physical 
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demand such as from rest to exercise can help clarify the interconnection between 
cerebrovascular health and brain function/dysfunction.  
 
 The present investigation suggests that there are not systematic differences in response 
kinetics or Amp between right and left MCA in healthy adults. This finding supports that either 
the left or right MCA can be used as an indicator of the kinetics response in both arteries during 
bilateral lower extremity exercise although this notion should be tested in larger and possibly 
more diverse populations. However, we do not know whether systematic lateral differences exist 
in the presence of neurologic injury such as stroke. Understanding whether true differences exist 




 Herein, we present what we hope will prove to be a sensitive technique for assessing the 
kinetics of cerebrovascular regulation with exercise (or other interventions). It is anticipated that 
determination of MCAV kinetics will be especially valuable for investigating cerebrovascular 
function in those at risk for, or suffering from, neurologic disease. Detecting improvements in 
cerebrovascular function following therapeutic or exercise interventions especially as these relate 
to response kinetics as well as amplitude would be a powerful capability for refining/assessing 





 First, we are unable to measure changes in MCA diameter. The assumption of constant 
MCA diameter is critical for MCAV to be used as a direct proxy for cerebral blood flow in the 
absence of direct diameter measures. Prior work has not permitted consensus as to whether MCA 
diameter changes with exercise or not (266, 267). Whereas there are some reports that MCA 
diameter is invariant under hypercapnic, hypocapnic and orthostatic challenges (72, 195, 249, 
268-271) there is also evidence for MCA diameter changing dynamically with motor activity 
(272) and visual stimulation (268, 273), though fluctuations may be very modest in larger vessels 
such as the MCA (268, 273). It is also thought that cerebral vessels may undergo regular 
oscillation at rest (274). If so, a dynamic challenge such as exercise might be important for 
improving the signal-to-noise ratio for assessment of cerebrovascular function.  
 
 Second, the values presented in this investigation represent a small population and 
therefore should not be considered to span the normal range for cerebrovascular responses in 
young healthy adults. We provide cardiovascular risk and estimated V̇O2max as descriptive 
measures of general cardiovascular health. A much broader range of ages and diseases must be 
characterized with this technique to approach generalizability, as appropriate. Additionally, the 
inability to demonstrate significantly lower response AMP in the older subject cohort was 
undoubtedly due to the small subject number and consequently low statistical power.  
 
 Third, the kinetics parameters reported here must, to some degree, be dependent upon the 
extant experimental conditions and not necessarily indicative of the capacity of the system to 
adapt to all moderate-intensity exercise challenges. For example, in order to minimize movement 
artifact we chose to increase work rate over 30 s rather than measuring the response to an 
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immediate step-increase to the intended work rate. It is likely that our kinetics parameters may 
have been different had we chosen a different forcing function. However, we specifically 
selected an exercise modality and test that does not compromise cranial stability and thus signal 
fidelity making them suitable for young healthy subjects as well as their older counterparts, and, 
crucially, many stroke patients.  
 
 Fourth, changes in MAP and also the partial pressure of arterial CO2 (PCO2) can impact 
MCAV via alterations of driving pressure and also downstream vascular (arteriolar) resistance, 
respectively. For the moderate-intensity exercise used herein MAP increased 8 mmHg (P=0.08) 
during exercise. The correlation between ΔMCAV and ΔMAP was not significant with <40% of 
the MCAV variance being potentially explained by MAP. With respect to PETCO2 it is important 
to note that PETCO2 is not the same as arterial PCO2 and the increase from 36 to 42 mmHg 
(P<0.01) is expected to arise from the altered breathing pattern and rate of CO2 evolution rather 
than altered arterial PCO2. Indeed, for moderate intensity exercise a substantial literature 
supports that humans regulate their arterial PCO2 ~40 mmHg (275). As for MAP there was no 
significant correlation between changes in PETCO2 and MCAV. For our experimental purposes it 
was important to track PETCO2 to ensure that the subjects did not hyperventilate (i.e., drive down 
PETCO2) due to excitement, nervousness or some other non-specific ventilatory responses, which 
would have induced cerebral arteriolar vasoconstriction. As the PETCO2 - arterial PCO2 
difference is inversely related to breathing frequency and directly related to tidal volume and 
CO2 output, for the exercise intensity herein the work of Jones and colleagues (26) supports that 





 Current work in healthy adults considers that moderate intensity exercise may be 
beneficial for motor learning (276) while other studies report high or vigorous intensity results in 
improved performance (277, 278). If the premise for improving motor learning is related to 
increased cerebral blood flow, we need to consider what exercise intensity, duration and 
frequency evokes the greatest increase in cerebral blood flow. As mentioned previously, there is 
evidence that moderate exercise intensities do increase cerebral blood flow whereas cerebral 
arteriolar vasoconstriction reduces blood flow at higher exercise intensities due to the arterial 
acidemia and consequent peripheral chemoreceptor-mediated hyperventilation and hypocapnia 
(83, 170, 174-176, 232, 233). Future work should include the MCAV kinetics response in 
addition to Amp and consider how they relate across specific age groups and chronic health 
conditions and whether there might be gender-related differences. 
 
 In conclusion, we have described a method for assessing the kinetics of cerebrovascular 
response to exercise. We present evidence for symmetrical vascular responses in young healthy 
subjects and preliminary data supporting notable differences in the MCAV response kinetics 
parameters related to age and cerebrovascular damage. With the growing interest in exercise 
benefits for the brain ecologically valid methods for measuring cerebrovascular response kinetics 
across the transition from rest to exercise may become an established investigative technique. 
Future work should explore the reliability, sensitivity and specificity of this technique across 
populations of interest with a view to determining the potential efficacy of therapeutic 
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